Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	carnitine O-palmitoyltransferase activity	CPT1A CPT1B CPT2	7.50e-06	4	248	3	GO:0004095
GeneOntologyMolecularFunction	O-palmitoyltransferase activity	CPT1A CPT1B CPT2	1.86e-05	5	248	3	GO:0016416
GeneOntologyMolecularFunction	carnitine O-acyltransferase activity	CPT1A CPT1B CPT2	3.68e-05	6	248	3	GO:0016406
GeneOntologyMolecularFunction	ATP-dependent activity	HSP90B2P ABCA13 ZGRF1 BCS1L DDX1 LONP1 ATP13A3 ABCG2 DNAH8 MRE11 ATG7 NLRP1 ABCF2 CCT2 ATP9A DICER1 DNAH1 MACF1 MORC3 AQR	8.89e-05	614	248	20	GO:0140657
GeneOntologyMolecularFunction	dynein intermediate chain binding	BICD1 DNAAF5 DNAH8 DNAH1 PAFAH1B1	8.94e-05	37	248	5	GO:0045505
GeneOntologyMolecularFunction	hemoglobin beta binding	HBB HBD	1.54e-04	2	248	2	GO:0031722
GeneOntologyMolecularFunction	ATP hydrolysis activity	HSP90B2P ABCA13 BCS1L DDX1 LONP1 ATP13A3 ABCG2 DNAH8 NLRP1 ABCF2 CCT2 ATP9A MACF1 MORC3 AQR	4.35e-04	441	248	15	GO:0016887
GeneOntologyMolecularFunction	proteinase activated receptor binding	BICD1 PHB1	4.57e-04	3	248	2	GO:0031871
GeneOntologyBiologicalProcess	carnitine shuttle	CPT1A CPT1B CPT2	6.40e-06	4	243	3	GO:0006853
GeneOntologyCellularComponent	early endosome	WIPF3 WASHC2A PHB1 CLCN3 NIPA2 ATP13A3 PML WASHC2C NUCB1 APOB ATP9A AP3B1 VAC14 APPL2 EGFR NISCH AP3B2 VPS35 TLR3 ZFYVE26 EPHA3	3.50e-07	481	249	21	GO:0005769
GeneOntologyCellularComponent	endosome	RAB9B WIPF3 GCGR WASHC2A ZP2 PHB1 RAB9A CLCN3 NIPA2 ATP13A3 PML SLC9A8 WASHC2C NUCB1 ARFGEF2 APOB ATP9A AP3B1 ARHGAP1 VAC14 APPL2 EGFR NISCH AP3B2 VPS35 TLR3 ZFYVE26 FYN EPHA3	1.48e-04	1167	249	29	GO:0005768
Domain	WD_REPEATS_1	IFT140 NLE1 WDR90 HERC1 DCAF12 RBBP7 DNAI3 NBAS SCAP TBC1D31 GTF3C2 PAFAH1B1 KCTD3 MAPKBP1	2.13e-05	278	247	14	PS00678
Domain	WD_REPEATS_2	IFT140 NLE1 WDR90 HERC1 DCAF12 RBBP7 DNAI3 NBAS SCAP TBC1D31 GTF3C2 PAFAH1B1 KCTD3 MAPKBP1	2.22e-05	279	247	14	PS50082
Domain	WD_REPEATS_REGION	IFT140 NLE1 WDR90 HERC1 DCAF12 RBBP7 DNAI3 NBAS SCAP TBC1D31 GTF3C2 PAFAH1B1 KCTD3 MAPKBP1	2.22e-05	279	247	14	PS50294
Domain	-	IFT140 NLE1 WDR90 SEMA4A HERC1 DCAF12 RBBP7 DNAI3 NBAS SCAP TBC1D31 GTF3C2 PAFAH1B1 KCTD3 MAPKBP1	3.96e-05	333	247	15	2.130.10.10
Domain	WD40/YVTN_repeat-like_dom	IFT140 NLE1 WDR90 SEMA4A HERC1 DCAF12 RBBP7 DNAI3 NBAS SCAP TBC1D31 GTF3C2 PAFAH1B1 KCTD3 MAPKBP1	4.24e-05	335	247	15	IPR015943
Domain	WD40_repeat_dom	IFT140 GTF3C4 NLE1 WDR90 HERC1 DCAF12 RBBP7 DNAI3 SCAP TBC1D31 GTF3C2 PAFAH1B1 KCTD3 MAPKBP1	4.40e-05	297	247	14	IPR017986
Domain	WD40	IFT140 NLE1 WDR90 HERC1 DCAF12 RBBP7 DNAI3 SCAP TBC1D31 GTF3C2 PAFAH1B1 KCTD3 MAPKBP1	6.16e-05	268	247	13	SM00320
Domain	WD40_repeat_CS	NLE1 WDR90 HERC1 DCAF12 RBBP7 SCAP TBC1D31 GTF3C2 PAFAH1B1 KCTD3	6.74e-05	164	247	10	IPR019775
Domain	WD40_repeat	IFT140 NLE1 WDR90 HERC1 DCAF12 RBBP7 DNAI3 SCAP TBC1D31 GTF3C2 PAFAH1B1 KCTD3 MAPKBP1	7.16e-05	272	247	13	IPR001680
Domain	Carn_acyl_trans	CPT1A CPT1B CPT2	7.69e-05	7	247	3	IPR000542
Domain	Carn_acyltransf	CPT1A CPT1B CPT2	7.69e-05	7	247	3	PF00755
Domain	ACYLTRANSF_C_1	CPT1A CPT1B CPT2	7.69e-05	7	247	3	PS00439
Domain	ACYLTRANSF_C_2	CPT1A CPT1B CPT2	7.69e-05	7	247	3	PS00440
Domain	AP3_beta	AP3B1 AP3B2	1.74e-04	2	247	2	IPR026740
Domain	AP3B_C	AP3B1 AP3B2	1.74e-04	2	247	2	IPR029390
Domain	AP3B1_C	AP3B1 AP3B2	1.74e-04	2	247	2	PF14796
Domain	AP3B1_C	AP3B1 AP3B2	1.74e-04	2	247	2	SM01355
Domain	FAM21	WASHC2A WASHC2C	1.74e-04	2	247	2	IPR027308
Domain	ARM-type_fold	CAB39 INTS1 TRIP12 DNAAF5 FMNL1 MROH9 MROH2A ARFGEF2 APOB AP3B1 VIRMA VAC14 AP3B2 VPS35	1.79e-04	339	247	14	IPR016024
Domain	WD40	IFT140 NLE1 WDR90 HERC1 DCAF12 RBBP7 DNAI3 SCAP TBC1D31 GTF3C2 PAFAH1B1 MAPKBP1	1.81e-04	259	247	12	PF00400
Domain	L_dom-like	ERBIN CEP78 TONSL PKD1 NXF2 NLRP1 PRAMEF13 EGFR NISCH TLR2 TLR3 LUM DRC3	4.48e-04	328	247	13	IPR032675
Domain	CAP-ZIP_m	WASHC2A WASHC2C	5.18e-04	3	247	2	PF15255
Domain	CPT_N	CPT1A CPT1B	5.18e-04	3	247	2	IPR032476
Domain	FAM21/CAPZIP	WASHC2A WASHC2C	5.18e-04	3	247	2	IPR029341
Domain	RTT107_BRCT_5	SLF1 PAXIP1	5.18e-04	3	247	2	PF16770
Domain	CPT_N	CPT1A CPT1B	5.18e-04	3	247	2	PF16484
Domain	LRR_6	CEP78 TONSL NLRP1 TLR3 LUM	7.88e-04	55	247	5	PF13516
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	VWA5B2 KCTD12 INTS1 ADGRB2 KDM3B IPP WASHC2A KIAA2013 MAP3K5 RHPN1 FASN NFATC1 PKD1 NLE1 WDR90 HERC1 FEM1A ARFGEF2 RGS16 VAC14 SCAP SSU72 NISCH DUSP16 PAXIP1 NINL PDCD11 ZFYVE26 MAPKBP1 ELL	4.77e-10	1105	249	30	35748872
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	WASF3 KDM3B ERBIN SYNE2 USP15 MRTFA SLC9A8 ANGPT1 RALGAPB DICER1 SCAP MACF1 KAT6B NIN	1.09e-09	225	249	14	12168954
Pubmed	Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.	CCPG1 GART RPS14 GTF3C4 DDX1 PHB1 FASN FAF2 MOGS TONSL FKBP3 NUMA1 CCT2 CPT1A AP3B1 CYFIP2 DNAH1 ARHGAP1 NBAS LRPPRC MACF1 HBB PGM2 MYO16	5.15e-09	807	249	24	30575818
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	STUB1 INTS1 KDM3B POLA2 GTF3C4 DDX1 PHB1 FANCD2 LONP1 FASN SERPINB5 TCERG1 UCHL5 PYGL FKBP3 PML MRE11 ATG7 RBBP7 NUMA1 CCT2 AHSA1 VIRMA SETD2 GTF3C2 SSU72 AQR	5.65e-09	1014	249	27	32416067
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	CCPG1 STUB1 WASHC2A BCS1L ERBIN PHB1 FAF2 MOGS PMPCA ERAP2 SYNE2 BUB1B NLE1 PML MTERF3 RALGAPB NUCB1 LAMC1 RRP8 AP3B1 DICER1 ARHGAP1 NBAS LRPPRC TBC1D31 GTF3C2 EGFR NISCH VPS35 PDCD11 MACF1 AQR NIN	9.19e-09	1487	249	33	33957083
Pubmed	FBW7 suppresses ovarian cancer development by targeting the N6-methyladenosine binding protein YTHDF2.	GART RPS14 TRIP12 POF1B DDX1 LONP1 FAF2 MOGS CEP78 PYGL MRE11 RBBP7 RALGAPB NUMA1 ABCF2 CCT2 LRPPRC GTF3C2 VPS35 MACF1	1.65e-08	601	249	20	33658012
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	CCPG1 GART RPS14 KDM3B TRIM65 POLA2 TRIP12 DNAAF5 FASN RAB9A MOGS SYNE2 NLE1 NUCB1 NUMA1 LAMC1 CCT2 APOB CPT1A ARHGAP1 GLMN LRPPRC FADS1 EGFR PAFAH1B1 PDCD11 MACF1 FYN PGM2 AQR	1.86e-08	1297	249	30	33545068
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	KCTD12 STUB1 GART RPS14 KDM3B POLA2 WASHC2A GTF3C4 DDX1 FANCD2 DNAAF5 FASN UCHL5 EIF2B2 BUB1B PYGL HERC1 USP15 FKBP3 MRE11 ATG7 RBBP7 NUCB1 ARFGEF2 ABCF2 CCT2 AP3B1 AHSA1 APPL2 PAFAH1B1 VPS35 MACF1	1.95e-08	1455	249	32	22863883
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	TRPM6 KCTD12 GART RPS14 DDX1 PHB1 FANCD2 LONP1 FASN RAB9A FAF2 MOGS PMPCA TCERG1 UCHL5 FKBP3 MRE11 NUMA1 ABCF2 CCT2 APOB AP3B1 AHSA1 DICER1 CYFIP2 GLMN LRPPRC GTF3C2 VPS35 PDCD11 AQR	4.23e-08	1425	249	31	30948266
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	KCTD12 HSP90B2P STUB1 TRIM65 POF1B FANCD2 DNAAF5 FASN FAF2 PMPCA PYGL MRE11 RBBP7 LAMC1 ABCF2 CPT1A AP3B1 DICER1 ARHGAP1 LRPPRC FLAD1 VPS35 DUSP16 KCTD3 GPSM1	4.37e-08	974	249	25	28675297
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	GART INTS1 RPS14 TRIP12 LONP1 FASN SYNE2 NLE1 PYGL MRE11 RBBP7 NUMA1 CCT2 RRP8 VIRMA DICER1 LRPPRC PDCD11 MACF1 AQR	6.42e-08	653	249	20	22586326
Pubmed	Defining the human deubiquitinating enzyme interaction landscape.	KDM3B IFIT5 POLA2 TRIP12 PHB1 LONP1 FAF2 USP38 PMPCA UCHL5 PYGL USP15 FEM1A MRE11 RBBP7 RRP8 DICER1 LRPPRC SSU72 VPS35 KCTD3 HBB ELL AQR NIN	7.93e-08	1005	249	25	19615732
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	WASHC2A POF1B GTF3C4 PHB1 FANCB FASN SERPINB5 CEP78 BUB1B ABCG2 HOMER3 DCAF12 WASHC2C NUMA1 XDH CCT2 CPS1 NBAS TRIM69 GTF3C2 PAFAH1B1 ITSN2 IFFO2 MORC3 FYN AQR TGS1	8.17e-08	1155	249	27	20360068
Pubmed	LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.	TRIP12 DDX1 KIAA2013 PHB1 FANCD2 DNAAF5 FASN FAF2 MOGS CEP78 UCHL5 EIF2B2 ABCF2 GALNT12 CPT1A ATP9A AP3B1 GLMN LRPPRC VAC14 FADS1 SCAP NISCH VPS35	9.46e-08	942	249	24	31073040
Pubmed	SERBP1 Promotes Stress Granule Clearance by Regulating 26S Proteasome Activity and G3BP1 Ubiquitination and Protects Male Germ Cells from Thermostimuli Damage.	GART RPS14 TRIP12 PHB1 FANCD2 DNAAF5 LONP1 FASN FAF2 PMPCA TCERG1 UCHL5 USP15 ATG7 RBBP7 ABCF2 CCT2 AHSA1 ARHGAP1 LRPPRC FLAD1 VPS35 PGM2	1.09e-07	878	249	23	37223481
Pubmed	ARHGAP24 represses β-catenin transactivation-induced invasiveness in hepatocellular carcinoma mainly by acting as a GTPase-independent scaffold.	TRPM6 GART GTF3C4 DDX1 DNAAF5 MOGS PYGL GAPDHS DHTKD1 MRE11 CCT2 CPS1 AP3B1 VAC14 VPS35 HBB	1.99e-07	451	249	16	36168627
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	UBR1 STUB1 KDM3B POLA2 TRIP12 ERBIN GTF3C4 FANCD2 FASN MRTFA MOCOS MRE11 SEC16B WASHC2C RALGAPB NUMA1 ARFGEF2 VIRMA SETD2 EGFR KAT6B	2.24e-07	774	249	21	15302935
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	GON4L WASHC2A ERBIN FAF2 USP15 WASHC2C RALGAPB ATP9A VIRMA NISCH SPHKAP ITSN2 MACF1 MAPKBP1 AQR	2.98e-07	407	249	15	12693553
Pubmed	Transgenic rescue of erythroid 5-aminolevulinate synthase-deficient mice results in the formation of ring sideroblasts and siderocytes.	ALAS2 HBB HBD	3.63e-07	3	249	3	16716198
Pubmed	Inhibition by etomoxir of rat liver carnitine octanoyltransferase is produced through the co-ordinate interaction with two histidine residues.	CPT1A CPT1B CPT2	3.63e-07	3	249	3	11023836
Pubmed	Genomic structure of and a cardiac promoter for the mouse carnitine palmitoyltransferase II gene.	CPT1A CPT1B CPT2	3.63e-07	3	249	3	8307575
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	KCTD12 CAB39 HSP90B2P RPS14 ERBIN DDX1 LONP1 FASN PTPRZ1 AKR1B10 HOMER3 RBBP7 ARFGEF2 CCT2 ATP9A AP3B1 VIRMA CYFIP2 LRPPRC APPL2 NISCH VCAN PAFAH1B1 AP3B2 VPS35 ITSN2 MACF1 HBB HBD	5.17e-07	1431	249	29	37142655
Pubmed	The E3 ubiquitin ligase FBXL6 controls the quality of newly synthesized mitochondrial ribosomal proteins.	KCTD12 STUB1 GON4L POF1B GTF3C4 LONP1 MOGS UCHL5 MRE11 RBBP7 ABCF2 CCT2 AHSA1 DICER1 GLMN IBTK GTF3C2	5.25e-07	547	249	17	37267103
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	KCTD12 STUB1 ERBIN DDX1 PHB1 FANCD2 DNAAF5 LONP1 FASN FAF2 SYNE2 EIF2B2 BUB1B ATP13A3 PML RBBP7 NUMA1 LAMC1 ABCF2 CCT2 RRP8 MUC13 DICER1 GLMN NBAS LRPPRC FADS1 VPS35 PDCD11	5.87e-07	1440	249	29	30833792
Pubmed	Fibril treatment changes protein interactions of tau and α-synuclein in human neurons.	INTS1 TRIP12 FAF2 SYNE2 PYGL FKBP3 RBBP7 NUMA1 AP3B1 ARHGAP1 APPL2 VCAN AP3B2 MACF1 FYN AQR	7.41e-07	498	249	16	36634849
Pubmed	HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways.	TRIM65 GTF3C4 PHB1 FANCD2 FASN FAF2 MOGS PMPCA UCHL5 PYGL USP15 RBBP7 ABCF2 CCT2 AHSA1 FLAD1 VPS35	9.46e-07	571	249	17	37167062
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	KCTD12 GART RPS14 IFIT5 ERBIN PHB1 FASN TCERG1 BUB1B MRE11 NUMA1 ABCF2 CCT2 AP3B1 ARHGAP1 LRPPRC EGFR MACF1 EPHA3	1.01e-06	708	249	19	39231216
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	UBR1 KDM3B GON4L DDX1 CLCN3 MOGS CEP78 TCERG1 TONSL BUB1B GAPDHS MOCOS RALGAPB AP3B1 DICER1 IBTK NISCH AQR	1.27e-06	650	249	18	38777146
Pubmed	Cell cycle-dependent phosphorylation regulates RECQL4 pathway choice and ubiquitination in DNA double-strand break repair.	STUB1 GART RPS14 GTF3C4 DDX1 PHB1 FANCD2 LONP1 FASN FAF2 MOGS CEP78 PMPCA UCHL5 EIF2B2 USP15 MRE11 ATG7 RBBP7 MTERF3 CCT2 AHSA1 DICER1 LRPPRC GTF3C2 FLAD1 VPS35	1.37e-06	1335	249	27	29229926
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	GART RPS14 TRIP12 GTF3C4 DDX1 PHB1 FASN MOGS TCERG1 NLE1 GAPDHS FKBP3 PML MRE11 NUMA1 ABCF2 CCT2 RRP8 AHSA1 VIRMA ARHGAP1 LRPPRC EGFR PDCD11 HBD AQR	1.44e-06	1257	249	26	36526897
Pubmed	Haplotype analysis of carnitine transporters and left ventricular mass in human essential hypertension.	CPT1A CPT1B CPT2	1.44e-06	4	249	3	15647998
Pubmed	Increased expression of carnitine palmitoyltransferase I gene is repressed by administering L-carnitine in the hearts of carnitine-deficient juvenile visceral steatosis mice.	CPT1A CPT1B CPT2	1.44e-06	4	249	3	8830050
Pubmed	The Carnitine Palmitoyl Transferase (CPT) System and Possible Relevance for Neuropsychiatric and Neurological Conditions.	CPT1A CPT1B CPT2	1.44e-06	4	249	3	26041663
Pubmed	Innate immunity of the ocular surface and ocular surface inflammatory disorders.	NFKBIZ TLR2 TLR3	1.44e-06	4	249	3	18813073
Pubmed	Palmitoylation of the HIV-1 envelope glycoprotein is critical for viral infectivity.	CPT1A CPT1B CPT2	1.44e-06	4	249	3	11095714
Pubmed	The ubiquitin-specific protease USP2a enhances tumor progression by targeting cyclin A1 in bladder cancer.	FASN CCNA1 EGFR	1.44e-06	4	249	3	22370483
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	INTS1 POLA2 TRIP12 POF1B GTF3C4 PML MRE11 DPY19L1 RBBP7 NUMA1 NFKBIZ IBTK GTF3C2 MORC3 AQR	1.75e-06	469	249	15	27634302
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	IFIT5 TRIP12 ERBIN DDX1 KIAA2013 PHB1 FASN CLCN3 PMPCA SYNE2 NLE1 ALAS2 DNAH8 TTC24 PCDHGB7 PCDHGA9 NUCB1 NUMA1 ABCF2 CCT2 APOB CYFIP2 RGS14 LRPPRC TBC1D31 VPS35 ITSN2 MACF1	1.89e-06	1442	249	28	35575683
Pubmed	RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling.	FASN NPC1L1 NUMA1 LAMC1 CPT1A VIRMA LRPPRC NISCH PDCD11 AQR	2.21e-06	202	249	10	24639526
Pubmed	USP11 mediates repair of DNA-protein cross-links by deubiquitinating SPRTN metalloprotease.	RPS14 DDX1 PHB1 FASN RAB9A FAF2 MRE11 ABCF2 CCT2 CPS1 CPT1A AHSA1 LRPPRC NISCH HBB PGM2	3.76e-06	565	249	16	33567341
Pubmed	Proximity labeling of endogenous RICTOR identifies mTOR complex 2 regulation by ADP ribosylation factor ARF1.	WASHC2A ERBIN ZNF354C FANCD2 TCERG1 FKBP3 WASHC2C RBBP7 ARFGEF2 CCT2	3.85e-06	215	249	10	35973513
Pubmed	Defining the membrane proteome of NK cells.	INTS1 RPS14 DDX1 KIAA2013 PHB1 LONP1 FASN CLCN3 MOGS ATP13A3 FMNL1 DPY19L1 NUCB1 ARFGEF2 OAS2 ABCF2 CPT1A AP3B1 CYFIP2 NBAS LRPPRC FADS1 NISCH AQR	4.18e-06	1168	249	24	19946888
Pubmed	LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells.	RPS14 ADGRG4 GTF3C4 LONP1 MOGS CEP78 TCERG1 BUB1B RBBP7 LAMC1 CCT2 DICER1 MMRN1 LRPPRC NINL HBB HBD	4.27e-06	639	249	17	23443559
Pubmed	Nuclear actin interactome analysis links actin to KAT14 histone acetyl transferase and mRNA splicing.	WIPF3 KDM3B POLA2 WASHC2A GTF3C4 DDX1 PHB1 FASN TCERG1 MRTFA RBBP7 NUMA1 CCT2 CYFIP2 AQR	4.40e-06	506	249	15	30890647
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	GART INTS1 RPS14 TRIP12 DDX1 PHB1 LONP1 FASN RAB9A SYNE2 NLE1 MRE11 NUMA1 LAMC1 ABCF2 CCT2 DICER1 LRPPRC PDCD11 MACF1 FYN AQR	5.34e-06	1024	249	22	24711643
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	UBR1 GART RPS14 TRIP12 ERBIN GTF3C4 DDX1 PHB1 ALKBH1 LONP1 FASN FAF2 TCERG1 NLE1 PYGL MRE11 NUMA1 ABCF2 CCT2 LRPPRC GTF3C2 PAFAH1B1 VPS35 PDCD11 MACF1 AQR	5.42e-06	1353	249	26	29467282
Pubmed	Prediction of the coding sequences of unidentified human genes. XXI. The complete sequences of 60 new cDNA clones from brain which code for large proteins.	CSMD2 RHPN1 USP38 WDR90 DCAF12 SEC16B	6.12e-06	63	249	6	11572484
Pubmed	Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.	HSP90B2P STUB1 GART INTS1 RPS14 BCS1L DDX1 PHB1 LONP1 FASN FAF2 MOGS TCERG1 NUCB1 LAMC1 OAS2 ABCF2 CCT2 CPT2 CYFIP2 LRPPRC FADS1 EGFR VPS35 TLR3 HBB HBD	6.36e-06	1451	249	27	30550785
Pubmed	Proteomics analysis of cardiac extracellular matrix remodeling in a porcine model of ischemia/reperfusion injury.	COL6A3 LAMC1 APOB FREM3 VCAN LUM	6.72e-06	64	249	6	22261194
Pubmed	Spatiotemporal-resolved protein networks profiling with photoactivation dependent proximity labeling.	STUB1 KDM3B TCERG1 UCHL5 HOMER3 PML MRE11 RBBP7 NUMA1 AHSA1 SETD2 SSU72 PAFAH1B1	7.09e-06	399	249	13	35987950
Pubmed	Genomics of the human carnitine acyltransferase genes.	CPT1A CPT1B CPT2	7.14e-06	6	249	3	11001805
Pubmed	Frem3, a member of the 12 CSPG repeats-containing extracellular matrix protein family, is a basement membrane protein with tissue distribution patterns distinct from those of Fras1, Frem2, and QBRICK/Frem1.	FREM1 LAMC1 FREM3	7.14e-06	6	249	3	17462874
Pubmed	AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism.	CAB39 CPT1A CPT1B CPT2	7.25e-06	18	249	4	16054041
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	ERBIN FANCD2 LONP1 PMPCA PTPRZ1 UCHL5 SYNE2 KCNMA1 HERC1 RALGAPB CCT2 PPM1K AP3B1 CYFIP2 ARHGAP1 GLMN TBC1D31 EGFR SSU72 DUSP16 KCTD3 NIN	7.79e-06	1049	249	22	27880917
Pubmed	Identification of different proteins binding to Na, K-ATPase α1 in LPS-induced ARDS cell model by proteomic analysis.	TRIP12 FASN FAF2 CCT2 CPS1 LRPPRC EGFR PDCD11	1.00e-05	144	249	8	35681168
Pubmed	Tumor suppressor BAP1 nuclear import is governed by transportin-1.	KCTD12 STUB1 GART RPS14 DDX1 FASN TCERG1 UCHL5 PYGL FKBP3 MRE11 RBBP7 CCT2 CPT2 AP3B1 AHSA1 CYFIP2 LRPPRC VAC14 NISCH PAFAH1B1 VPS35 MACF1	1.02e-05	1149	249	23	35446349
Pubmed	An Interaction Landscape of Ubiquitin Signaling.	KDM3B TRIP12 FAF2 USP38 UCHL5 HERC1 USP15 PML LAMC1 CPT1A IBTK ITSN2 MACF1 MORC3	1.13e-05	481	249	14	28190767
Pubmed	The RepID-CRL4 ubiquitin ligase complex regulates metaphase to anaphase transition via BUB3 degradation.	BUB1B PML RBBP7 NUMA1	1.14e-05	20	249	4	31911655
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	KDM3B ERBIN GTF3C4 FASN TCERG1 BUB1B USP15 MRE11 RBBP7 NUMA1 CCT2 AP3B1 SETD2 GTF3C2 PDCD11	1.16e-05	549	249	15	38280479
Pubmed	N- and C-terminal transactivation domains of GATA1 protein coordinate hematopoietic program.	ALAS2 HBB HBD	1.24e-05	7	249	3	22556427
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	TRPM6 ANO9 WASHC2A TRIP12 ERBIN HAVCR1 HERC1 CPLANE1 MRTFA PML MRE11 WASHC2C NFKBIZ APOB CPT2 AP3B1 PRAMEF13 SCAP TBC1D31 VCAN MACF1 TGS1	1.29e-05	1084	249	22	11544199
Pubmed	Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.	CCPG1 RPS14 TRIP12 GTF3C4 DDX1 FASN TCERG1 MRE11 WASHC2C RBBP7 NUMA1 ABCF2 RRP8 CPS1 CPT1A GTF3C2 PDCD11 ELL AQR	1.32e-05	847	249	19	35850772
Pubmed	Hepatitis B Virus HBx Protein Mediates the Degradation of Host Restriction Factors through the Cullin 4 DDB1 E3 Ubiquitin Ligase Complex.	POF1B DDX1 GAPDHS SEC16B LAMC1 AP3B1 LRPPRC VAC14 EGFR PAFAH1B1 MYBPC3	1.38e-05	304	249	11	32235678
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	STUB1 WASHC2A BICD1 LONP1 BUB1B CPLANE1 USP15 WASHC2C CCT2 ARHGAP1 GLMN IBTK TBC1D31 ITSN2 IFFO2 NINL MORC3 ELL NIN	1.45e-05	853	249	19	28718761
Pubmed	A multi-factor trafficking site on the spliceosome remodeling enzyme BRR2 recruits C9ORF78 to regulate alternative splicing.	POLA2 BCS1L GTF3C4 LONP1 MOGS TCERG1 WASHC2C NUMA1 AP3B1 AHSA1 GLMN LRPPRC GTF3C2 VPS35 AQR	1.46e-05	560	249	15	35241646
Pubmed	KAP1 facilitates reinstatement of heterochromatin after DNA replication.	RPS14 TRIP12 GTF3C4 FANCD2 FASN FAF2 NLE1 DNAH8 MRE11 NUMA1 CPS1 AP3B1 VIRMA NBAS SSU72 PAFAH1B1 PDCD11	1.50e-05	704	249	17	29955894
Pubmed	Blocking an N-terminal acetylation-dependent protein interaction inhibits an E3 ligase.	STUB1 GART RPS14 WASHC2A FASN UCHL5 PYGL USP15 RBBP7 CCT2 AHSA1 LRPPRC NISCH HBB	1.55e-05	495	249	14	28581483
Pubmed	Ex vivo Quantitative Proteomic Analysis of Serotonin Transporter Interactome: Network Impact of the SERT Ala56 Coding Variant.	KCTD12 ADGRB2 ERBIN PHB1 CPT1A ATP9A APPL2 VCAN AP3B2 KCTD3 MACF1 HBB HBD	1.57e-05	430	249	13	32581705
Pubmed	Multi-omics profiling identifies a deregulated FUS-MAP1B axis in ALS/FTD-associated UBQLN2 mutants.	DDX1 PHB1 FASN FAF2 ABCF2 CCT2 CPS1 CPT1A AHSA1 LRPPRC	1.77e-05	256	249	10	35777956
Pubmed	Inflammation-dependent overexpression of c-Myc enhances CRL4DCAF4 E3 ligase activity and promotes ubiquitination of ST7 in colitis-associated cancer.	POLA2 MAP3K5 MRTFA NLRP1 ABCF2 RGS14 SETD2 SPHKAP VPS35 ELL	1.83e-05	257	249	10	30945288
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	GON4L IFIT5 TRIP12 ERBIN PHB1 MOGS TONSL BUB1B WDR90 USP15 TBC1D31 GTF3C2 PAXIP1 MORC3 HBB NIN	1.94e-05	645	249	16	25281560
Pubmed	A "double adaptor" method for improved shotgun library construction.	KCTD12 BCS1L EIF2B2 NIPA2 HERC1 DCAF12 NLRP1 DICER1 AZIN1 LRPPRC FADS1 GTF3C2 FLAD1 VPS35 ITSN2	1.94e-05	574	249	15	8619474
Pubmed	Quantitative Lys-ϵ-Gly-Gly (diGly) proteomics coupled with inducible RNAi reveals ubiquitin-mediated proteolysis of DNA damage-inducible transcript 4 (DDIT4) by the E3 ligase HUWE1.	RPS14 DDX1 PHB1 FASN FAF2 UCHL5 PYGL USP15 MRE11 RBBP7 CCT2 AHSA1	2.01e-05	377	249	12	25147182
Pubmed	TIM-1 Ubiquitination Mediates Dengue Virus Entry.	STUB1 HAVCR1 ABCG2 FYN	2.04e-05	23	249	4	29742433
Pubmed	LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression.	GART RPS14 DDX1 PHB1 FASN CCT2 MUC13 CPS1 CPT1A AHSA1 LRPPRC EGFR VPS35 HBD FYN	2.19e-05	580	249	15	35676659
Pubmed	Proteomic characterization of chromosomal common fragile site (CFS)-associated proteins uncovers ATRX as a regulator of CFS stability.	ABCA13 INTS1 RPS14 GC POF1B PHB1 FANCD2 FANCB SERPINB5 PML MRE11 RBBP7 NUMA1 APOB LRPPRC HBB	2.21e-05	652	249	16	31180492
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	STUB1 ZGRF1 WASHC2A DDX1 TCERG1 NFATC1 TONSL PML CDCA4 WASHC2C RBBP7 SETD2 MACF1 MORC3 NIN	2.57e-05	588	249	15	38580884
Pubmed	Functional proteomics mapping of a human signaling pathway.	RPS14 KDM3B TRIP12 ERBIN PKD1 HERC1 FMNL1 MAN1C1 ARFGEF2 LAMC1 TRIM69 VPS35 PAXIP1 MACF1 PAPPA	2.72e-05	591	249	15	15231748
Pubmed	Molecular enzymology of carnitine transfer and transport.	CPT1A CPT1B CPT2	2.95e-05	9	249	3	11257506
Pubmed	Systematic proteomics of endogenous human cohesin reveals an interaction with diverse splicing factors and RNA-binding proteins required for mitotic progression.	INTS1 KDM3B TRIP12 POF1B GTF3C4 FASN NFATC1 LRPPRC PDCD11 HBB	2.97e-05	272	249	10	31010829
Pubmed	Identification of FOXJ1 effectors during ciliogenesis in the foetal respiratory epithelium and embryonic left-right organiser of the mouse.	XDH DNAI3 DUSP16 HBB HBD DRC3	3.02e-05	83	249	6	27914912
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	STUB1 RPS14 BCS1L PHB1 FANCD2 LONP1 FAF2 PMPCA SYNE2 HERC1 DHTKD1 MTIF3 MTERF3 CCT2 RRP8 CPT2 ARHGAP1 GLMN NBAS IBTK LRPPRC GTF3C2 NISCH FLAD1 ITSN2 PDCD11	3.06e-05	1496	249	26	32877691
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	INTS1 GON4L ERBIN KIAA2013 GREB1L TCERG1 HOMER3 FKBP3 MRE11 RBBP7 RALGAPB ABCF2 RRP8 ATP9A AP3B1 VIRMA DICER1 CYFIP2 SETD2 APPL2 GTF3C2 ITSN2 KCTD3 PDCD11 MACF1 AQR	3.09e-05	1497	249	26	31527615
Pubmed	WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage.	INTS1 GON4L TRIP12 GTF3C4 DDX1 TONSL MRE11 NUMA1 CCT2 AP3B1 LRPPRC PDCD11	3.09e-05	394	249	12	27248496
Pubmed	Transferrin Receptor Protein 1 Cooperates with mGluR2 To Mediate the Internalization of Rabies Virus and SARS-CoV-2.	STUB1 RPS14 TRIP12 DDX1 FAF2 MOGS GAPDHS ABCF2 AHSA1 LRPPRC PDCD11	3.19e-05	333	249	11	36779763
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	STUB1 GART RPS14 DDX1 PHB1 LONP1 FASN FAF2 MOGS TCERG1 SYNE2 FKBP3 MRE11 RBBP7 NUMA1 ABCF2 CCT2 CPS1 CPT1A AP3B1 LRPPRC EGFR VPS35 MACF1 AQR	3.36e-05	1415	249	25	28515276
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	CAB39 INTS1 POLA2 FANCD2 FASN MOGS ATP13A3 MRE11 SLF1 RBBP7 RALGAPB VIRMA DICER1 AZIN1 LMAN1L ARHGAP1 NBAS SETD2 SCAP SLC12A1 ZNF37A VPS35 PAXIP1 ELL	3.36e-05	1327	249	24	32694731
Pubmed	Mouse screen reveals multiple new genes underlying mouse and human hearing loss.	IFT140 TRIM65 WASHC2A EIF2B2 HERC1 FKBP3 VWA3A MROH9 SEC16B SLC9A8 WASHC2C RBBP7 RALGAPB CPT2 PRAMEF13 VIRMA CYFIP2 LRPPRC APPL2 EGFR PUS10 NINL FYN	3.44e-05	1242	249	23	30973865
Pubmed	The extracellular matrix gene Frem1 is essential for the normal adhesion of the embryonic epidermis.	FREM1 COL6A3 FREM3	4.19e-05	10	249	3	15345741
Pubmed	Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.	CCPG1 INTS1 WIPF3 POF1B GTF3C4 LONP1 NFATC1 NLE1 PYGL USP15 MRE11 MTERF3 LAMC1 CCT2 EGFR SEZ6	4.27e-05	689	249	16	36543142
Pubmed	TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex.	GART DDX1 FASN PYGL COL6A3 ABCF2 CPS1 VPS35	4.81e-05	179	249	8	36261009
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	KCTD12 GART KDM3B ERBIN GTF3C4 FASN TCERG1 BUB1B FKBP3 PML MRE11 WASHC2C RBBP7 NUMA1 CCT2 AHSA1 IBTK SETD2 MACF1	4.96e-05	934	249	19	33916271
Pubmed	PARK2 promotes mitochondrial pathway of apoptosis and antimicrotubule drugs chemosensitivity via degradation of phospho-BCL-2.	GART RPS14 GC PHB1 FASN FAF2 FKBP3 ABCF2 CCT2 AHSA1	5.09e-05	290	249	10	32929329
Pubmed	Expression of toll-like receptors 2 and 3 on esophageal epithelial cell lines and on eosinophils during esophagitis.	TLR2 TLR3	5.11e-05	2	249	2	21960283
Pubmed	Variants within the muscle and liver isoforms of the carnitine palmitoyltransferase I (CPT1) gene interact with fat intake to modulate indices of obesity in French-Canadians.	CPT1A CPT1B	5.11e-05	2	249	2	17089095
Pubmed	Regulation of cytoplasmic dynein ATPase by Lis1.	DNAH8 PAFAH1B1	5.11e-05	2	249	2	16481446
Pubmed	Variation in Niemann-Pick C1-like 1 gene as a determinant of apolipoprotein B-100 kinetics and response to statin therapy in centrally obese men.	NPC1L1 APOB	5.11e-05	2	249	2	18031309
Pubmed	Brain Distribution of a Panel of Epidermal Growth Factor Receptor Inhibitors Using Cassette Dosing in Wild-Type and Abcb1/Abcg2-Deficient Mice.	ABCG2 EGFR	5.11e-05	2	249	2	30705084
Pubmed	Hepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic mice.	HBB HBD	5.11e-05	2	249	2	21099112
Pubmed	Significance of nuclear EGFR and ABCG2 expression in malignant transformation of oral potentially malignant disorders.	ABCG2 EGFR	5.11e-05	2	249	2	36325600
Interaction	RICTOR interactions	GART RPS14 WASHC2A ERBIN POF1B ZNF354C PHB1 FANCD2 LONP1 FASN FAF2 MOGS TCERG1 NXF2 FKBP3 WASHC2C RBBP7 ARFGEF2 ABCF2 GALNT12 CCT2 CPS1 CPT1A AHSA1 VIRMA LRPPRC EGFR DUSP16	1.70e-07	759	244	28	int:RICTOR
Interaction	MEIOC interactions	FANCD2 NXF2 DUSP16 NINL NIN	1.37e-06	17	244	5	int:MEIOC
Interaction	WASF2 interactions	WASF3 POLA2 BICD1 TCERG1 HOMER3 ATG7 VIRMA CYFIP2 EGFR ITSN2 FYN	1.70e-06	146	244	11	int:WASF2
Interaction	SENP3 interactions	STUB1 TRIP12 GTF3C4 MOGS TONSL PYGL HERC1 USP15 PML MRE11 CYFIP2 GTF3C2 NISCH VPS35 PDCD11	4.31e-06	301	244	15	int:SENP3
Interaction	WASHC2C interactions	WASHC2A RAB9A USP15 PML WASHC2C AP3B1 VIRMA VPS35	4.65e-06	78	244	8	int:WASHC2C
Interaction	CAPZA1 interactions	WASHC2A BICD1 PHB1 FANCD2 UCHL5 WASHC2C NUMA1 CCT2 AP3B1 VIRMA ARHGAP1 RGS14 VPS35 PAXIP1 NINL NIN	1.08e-05	366	244	16	int:CAPZA1
Interaction	CLCN5 interactions	CLCN3 FEM1A VIRMA APPL2 EGFR	1.09e-05	25	244	5	int:CLCN5
Interaction	SLC10A7 interactions	GCGR EIF2B2 ATP13A3 PCDHGA9 APOB	1.09e-05	25	244	5	int:SLC10A7
Interaction	ACAD9 interactions	BCS1L POF1B PHB1 FANCD2 LONP1 FASN SERPINB5 FAF2 PMPCA NFATC1 DHTKD1 MTIF3 MTERF3 ABCF2 VIRMA LRPPRC FLAD1	1.61e-05	421	244	17	int:ACAD9
Interaction	HAVCR1 interactions	STUB1 HAVCR1 ABCG2 SEMA4A FYN	1.62e-05	27	244	5	int:HAVCR1
Interaction	TOP3B interactions	VWA5B2 KCTD12 INTS1 ADGRB2 KDM3B IPP WASHC2A KIAA2013 MAP3K5 PHB1 RHPN1 LONP1 FASN MOGS NFATC1 PKD1 NLE1 WDR90 HERC1 FEM1A FKBP3 ARFGEF2 APOB RGS16 IBTK VAC14 SCAP SSU72 NISCH DUSP16 PAXIP1 NINL PDCD11 ZFYVE26 MAPKBP1 HBD ELL	1.75e-05	1470	244	37	int:TOP3B
Interaction	PDK3 interactions	STUB1 FANCD2 LONP1 PMPCA MTIF3 CCT2 VIRMA LRPPRC EGFR	2.18e-05	125	244	9	int:PDK3
Interaction	APOA1 interactions	ABCA13 FANCD2 UCHL5 KCNMA1 USP15 MOCOS GPLD1 NLRP1 APOB MACF1 HBB	2.45e-05	193	244	11	int:APOA1
Interaction	VIPR2 interactions	INTS1 ERBIN KIAA2013 FANCD2 DNAAF5 ATP13A3 VIP VIRMA CYFIP2 GLMN RGS14	2.57e-05	194	244	11	int:VIPR2
Interaction	CLPX interactions	KCTD12 PHB1 FANCD2 LONP1 RAB9A PMPCA MTIF3 MTERF3 CYFIP2 LRPPRC EGFR	2.83e-05	196	244	11	int:CLPX
Interaction	FBXW7 interactions	GART RPS14 TRIP12 POF1B DDX1 FANCD2 LONP1 FAF2 MOGS USP38 CEP78 TONSL BUB1B PYGL PML MRE11 RBBP7 RALGAPB NUMA1 ABCF2 GALNT12 CCT2 VIRMA GLMN LRPPRC GTF3C2 EGFR VPS35 DUSP16 PAXIP1 MACF1 TGS1	2.90e-05	1215	244	32	int:FBXW7
Interaction	FBXL6 interactions	KCTD12 RAB9B STUB1 GON4L POF1B GTF3C4 LONP1 FASN MOGS UCHL5 MRE11 ATG7 RBBP7 ABCF2 CCT2 AHSA1 DICER1 GLMN IBTK GTF3C2	3.05e-05	583	244	20	int:FBXL6
Interaction	POP7 interactions	POLA2 PHB1 ATG7 RRP8 IBTK EGFR PDCD11	3.76e-05	76	244	7	int:POP7
Interaction	CENPE interactions	BICD1 BUB1B RBBP7 VIRMA LRPPRC PAFAH1B1 NINL NIN	4.47e-05	106	244	8	int:CENPE
Interaction	HSPB8 interactions	IFT140 STUB1 FANCD2 DNAAF5 TONSL PYGL GAPDHS PML ARFGEF2 SETD2	4.86e-05	172	244	10	int:HSPB8
Interaction	LGALS7 interactions	POLA2 POF1B FANCD2 SERPINB5 USP38 PKD1 USP15 PML VCAN	5.04e-05	139	244	9	int:LGALS7
Interaction	AK4 interactions	LONP1 PMPCA NIPA2 FKBP3 MTIF3 MTERF3 CPS1 CPT2 LRPPRC EGFR	5.10e-05	173	244	10	int:AK4
Interaction	METTL14 interactions	UBR1 STUB1 RPS14 DDX1 PHB1 MOGS PMPCA UCHL5 NLE1 HERC1 COL6A3 RBBP7 ABCF2 CCT2 CPS1 AHSA1 VIRMA LRPPRC EGFR	5.34e-05	558	244	19	int:METTL14
Interaction	KCNA3 interactions	KCTD12 ABCA13 GART RPS14 IFIT5 ERBIN PHB1 FASN FAF2 TCERG1 BUB1B PYGL MRE11 NUMA1 ABCF2 CCT2 AP3B1 ARHGAP1 LRPPRC EGFR AP3B2 TLR3 MACF1 FYN EPHA3	6.02e-05	871	244	25	int:KCNA3
Interaction	SPG11 interactions	FASN RAB9A VIRMA CYFIP2 DUSP16 ZFYVE26	6.41e-05	57	244	6	int:SPG11
Interaction	CIT interactions	HSP90B2P GART INTS1 RPS14 GCGR TRIP12 GTF3C4 DDX1 MAP3K5 BICD1 PHB1 LONP1 FASN FAF2 MOGS TCERG1 SYNE2 ABCG2 GAPDHS HERC1 RBBP7 NUMA1 CCT2 RRP8 APOB CPS1 VIRMA NBAS LRPPRC GTF3C2 PDCD11 MACF1 PGM2 AQR NIN	7.12e-05	1450	244	35	int:CIT
Interaction	GCAT interactions	FANCD2 LONP1 FAF2 CPS1 CPT2 NIN	8.58e-05	60	244	6	int:GCAT
Interaction	PSMD2 interactions	STUB1 FANCD2 FASN FAF2 UCHL5 USP15 PML ATG7 RBBP7 ARFGEF2 CCT2 AHSA1 VIRMA CYFIP2 LRPPRC EGFR	8.65e-05	435	244	16	int:PSMD2
Interaction	WAS interactions	TCERG1 ARHGAP1 RGS14 LRPPRC EGFR ITSN2 FYN	1.04e-04	89	244	7	int:WAS
Interaction	LRRFIP1 interactions	DDX1 FANCD2 SERPINB5 USP15 FKBP3 MRE11 RBBP7 NUMA1 RGS14	1.06e-04	153	244	9	int:LRRFIP1
Interaction	RFC4 interactions	POLA2 DDX1 FANCD2 NFATC1 EIF2B2 FKBP3 PML MRE11 IBTK EGFR PAXIP1	1.07e-04	227	244	11	int:RFC4
Interaction	MAP1B interactions	KCTD12 DDX1 PHB1 FANCD2 FASN FAF2 NXF2 PML RBBP7 ABCF2 CCT2 CPS1 CPT1A AHSA1 VIRMA LRPPRC PAFAH1B1 DUSP16	1.07e-04	539	244	18	int:MAP1B
Interaction	SPAG9 interactions	RPS14 GTF3C4 MAP3K5 RAB9A USP15 PML RBBP7 PPM1K VIRMA LRPPRC GTF3C2 VPS35	1.10e-04	268	244	12	int:SPAG9
Interaction	STIL interactions	STUB1 BICD1 FANCD2 WASHC2C ATG7 GLMN EGFR DUSP16 NINL NIN	1.12e-04	190	244	10	int:STIL
Interaction	CUL4A interactions	RPS14 POLA2 POF1B DDX1 MAP3K5 RAB9A GAPDHS DCAF12 SEC16B RBBP7 NUMA1 LAMC1 NLRP1 AP3B1 VIRMA DICER1 ARHGAP1 GLMN LRPPRC VAC14 EGFR PAFAH1B1 VPS35 MYBPC3	1.17e-04	854	244	24	int:CUL4A
Interaction	SUCLA2 interactions	STUB1 FANCD2 LONP1 FAF2 PMPCA KCNMA1 ALAS2 MTIF3 MTERF3 LRPPRC EGFR	1.24e-04	231	244	11	int:SUCLA2
Interaction	AVPR2 interactions	STUB1 INTS1 DNAAF5 CLCN3 ATP13A3 DPY19L1 GLMN FADS1	1.28e-04	123	244	8	int:AVPR2
Interaction	SKA3 interactions	STUB1 POF1B KIAA2013 BUB1B MRE11 ABCF2 AP3B1 PAFAH1B1 PAXIP1 NIN	1.32e-04	194	244	10	int:SKA3
Interaction	WDR83 interactions	BICD1 NUMA1 CCT2 VAC14 EGFR KCTD3 NINL GPSM1 AQR NIN	1.44e-04	196	244	10	int:WDR83
Interaction	SMC3 interactions	INTS1 GTF3C4 PHB1 FANCD2 FASN RAB9A NFATC1 USP15 RBBP7 NUMA1 VIRMA EGFR SSU72 PAXIP1 PDCD11	1.44e-04	408	244	15	int:SMC3
Interaction	NUP210P1 interactions	IFT140 TRIM65 POLA2 HBB HBD	1.47e-04	42	244	5	int:NUP210P1
Interaction	GFPT1 interactions	PHB1 FANCD2 DNAAF5 FASN AHSA1 VIRMA ARHGAP1 EGFR NIN	1.49e-04	160	244	9	int:GFPT1
Interaction	PFAS interactions	UBR1 GART GTF3C4 FANCD2 ATG7 VIRMA VAC14 EGFR FLAD1	1.49e-04	160	244	9	int:PFAS
Interaction	BIRC2 interactions	STUB1 MAP3K5 PHB1 USP15 PML DCAF12 MRE11 PPM1K GLMN EGFR TLR3	1.50e-04	236	244	11	int:BIRC2
Interaction	RAB4A interactions	RPS14 GCGR WASHC2A PHB1 FAF2 SYNE2 ATP13A3 FMNL1 WASHC2C RALGAPB ARFGEF2 ATP9A ARHGAP1 APPL2 EGFR NISCH	1.53e-04	457	244	16	int:RAB4A
Interaction	CCDC8 interactions	GART INTS1 RPS14 TRIP12 PHB1 FANCD2 FASN RAB9A RBBP7 MROH2A NUMA1 LAMC1 ABCF2 CCT2 APOB DICER1 LRPPRC PDCD11 MACF1 FYN	1.53e-04	656	244	20	int:CCDC8
Interaction	ZBTB40 interactions	FASN NFATC1 VIRMA RGS14	1.55e-04	23	244	4	int:ZBTB40
Interaction	BIRC3 interactions	KCTD12 GART RPS14 DDX1 PHB1 FANCD2 LONP1 FASN RAB9A FAF2 MOGS PMPCA TCERG1 UCHL5 USP15 FKBP3 MRE11 NUMA1 ABCF2 CCT2 APOB AP3B1 AHSA1 CYFIP2 GLMN LRPPRC GTF3C2 EGFR VPS35 TLR3 PDCD11 AQR	1.68e-04	1334	244	32	int:BIRC3
Interaction	COMTD1 interactions	CAB39 INTS1 KIAA2013 FANCD2 DNAAF5 EIF2B2 BUB1B CYFIP2 VAC14 PAXIP1	1.70e-04	200	244	10	int:COMTD1
Interaction	DIAPH2 interactions	DDX1 PMPCA TCERG1 FMNL1 VIRMA CYFIP2	1.73e-04	68	244	6	int:DIAPH2
Interaction	ABCF1 interactions	DDX1 PHB1 EIF2B2 FKBP3 FMNL1 MRE11 ATG7 VIRMA EGFR NINL	1.77e-04	201	244	10	int:ABCF1
Interaction	SNCA interactions	STUB1 INTS1 TRIP12 FASN FAF2 SYNE2 PYGL USP15 FKBP3 NUMA1 AP3B1 VIRMA ARHGAP1 APPL2 EGFR VCAN AP3B2 MACF1 FYN AQR TGS1	1.78e-04	716	244	21	int:SNCA
Interaction	AGR2 interactions	CCPG1 GART RPS14 GTF3C4 DDX1 PHB1 FASN FAF2 MOGS AKR1B10 TONSL FKBP3 NUMA1 CCT2 CPT1A AP3B1 CYFIP2 DNAH1 ARHGAP1 NBAS LRPPRC MACF1 HBB PGM2 MYO16	1.79e-04	934	244	25	int:AGR2
Interaction	C2CD4B interactions	ERBIN HERC1 DICER1 SETD2 MACF1	1.84e-04	44	244	5	int:C2CD4B
Interaction	CAPZB interactions	WASF3 RPS14 WASHC2A DDX1 BICD1 PHB1 FANCD2 LONP1 FASN UCHL5 ANGPT1 WASHC2C ATG7 NUMA1 ABCF2 CCT2 AP3B1 VIRMA CYFIP2 RGS14 LRPPRC EGFR PAFAH1B1 VPS35 PAXIP1 NINL NIN	1.85e-04	1049	244	27	int:CAPZB
Interaction	RAB7A interactions	KCTD12 WASHC2A BICD1 PHB1 FANCD2 RAB9A FAF2 UCHL5 SYNE2 ABCG2 WASHC2C ATG7 ARFGEF2 MUC13 CPT1A ATP9A VIRMA NBAS LRPPRC VAC14 SCAP APPL2 NISCH VPS35	2.03e-04	886	244	24	int:RAB7A
Interaction	VIPR1 interactions	TRPM6 INTS1 KIAA2013 FANCD2 VIP DPY19L1 MROH2A CYFIP2 GLMN SPHKAP	2.07e-04	205	244	10	int:VIPR1
Interaction	NPAS1 interactions	IFT140 STUB1 INTS1 TRIM65 POLA2 TRIP12 DNAAF5 TONSL HERC1 KCTD3 GPSM1	2.08e-04	245	244	11	int:NPAS1
Interaction	MCM6 interactions	GTF3C4 PHB1 FANCD2 FASN USP38 TONSL CCNA1 USP15 NUMA1 VIRMA EGFR PAXIP1	2.09e-04	287	244	12	int:MCM6
Interaction	NHLH2 interactions	ARFGEF2 AP3B1 GTF3C2 HBB	2.17e-04	25	244	4	int:NHLH2
Interaction	IFT81 interactions	BICD1 RHPN1 NLRP1 DUSP16 NINL NIN	2.20e-04	71	244	6	int:IFT81
Interaction	CEP295 interactions	BUB1B VIRMA PAFAH1B1 DUSP16 NINL NIN	2.20e-04	71	244	6	int:CEP295
Interaction	DNAJC7 interactions	IFT140 STUB1 GART PHB1 FANCD2 FANCB FASN NFATC1 BUB1B MOCOS CPS1 CYFIP2 ARHGAP1 GTF3C2 EGFR	2.25e-04	425	244	15	int:DNAJC7
Interaction	CMKLR1 interactions	INTS1 KIAA2013 FANCD2 DNAAF5 DPY19L1 ATP9A FADS1	2.29e-04	101	244	7	int:CMKLR1
Interaction	ATP1A1 interactions	TRIP12 PHB1 FANCD2 HAVCR1 FASN RAB9A FAF2 PKD1 KCNMA1 CCT2 CPS1 AHSA1 VIRMA LRPPRC SLC12A1 EGFR PDCD11 NIN	2.38e-04	575	244	18	int:ATP1A1
Interaction	WASHC4 interactions	WASHC2A RAB9A WASHC2C ATG7 AP3B1 VIRMA VPS35	2.43e-04	102	244	7	int:WASHC4
Interaction	TUBG1 interactions	STUB1 RPS14 PHB1 FANCD2 LONP1 FAF2 KCNMA1 ANGPT1 LAMC1 CCT2 CPS1 CPT1A EGFR NINL	2.48e-04	382	244	14	int:TUBG1
Interaction	PSMB7 interactions	UCHL5 PYGL USP15 RBBP7 NUMA1 VIRMA LRPPRC EGFR NINL SERPINA10	2.62e-04	211	244	10	int:PSMB7
Interaction	RUNDC3B interactions	CYFIP2 EGFR VPS35	2.69e-04	11	244	3	int:RUNDC3B
Interaction	ATF7IP interactions	TRIP12 PKD1 ARL14EP PML LAMC1 VIRMA MACF1 PAPPA	2.83e-04	138	244	8	int:ATF7IP
Interaction	ALAS1 interactions	LONP1 PMPCA ALAS2 MTIF3 MTERF3 LRPPRC EGFR ZFYVE26	2.97e-04	139	244	8	int:ALAS1
Interaction	PTGES3 interactions	IFT140 STUB1 ZGRF1 FANCB PYGL MOCOS AHSA1 VIRMA GLMN IBTK LRPPRC EGFR SSU72 DUSP16 PDCD11	3.02e-04	437	244	15	int:PTGES3
Interaction	ARHGAP24 interactions	TRPM6 GART GTF3C4 DDX1 DNAAF5 MOGS PYGL GAPDHS DHTKD1 MRE11 CCT2 CPS1 AP3B1 VAC14 VPS35 HBB	3.04e-04	486	244	16	int:ARHGAP24
Interaction	ARHGEF18 interactions	GART BICD1 CCT2 VIRMA EGFR	3.08e-04	49	244	5	int:ARHGEF18
Interaction	ACTC1 interactions	WIPF3 KDM3B GC POLA2 WASHC2A GTF3C4 DDX1 PHB1 FASN TCERG1 UCHL5 SYNE2 MRTFA RBBP7 NUMA1 CCT2 VIRMA CYFIP2 TNNI3K AQR	3.19e-04	694	244	20	int:ACTC1
Interaction	EED interactions	GART INTS1 RPS14 TRIP12 GTF3C4 DDX1 PHB1 FANCD2 FASN MOGS TCERG1 KCNMA1 MRE11 RBBP7 NUMA1 LAMC1 ABCF2 CCT2 RRP8 AP3B1 AHSA1 VIRMA ARHGAP1 GLMN LRPPRC TBC1D31 VPS35 ITSN2 PDCD11 MACF1 MORC3 AQR TGS1	3.23e-04	1445	244	33	int:EED
Interaction	RND2 interactions	ERBIN PHB1 LONP1 RAB9A FAF2 SYNE2 FMNL1 RALGAPB MUC13 ARHGAP1 RGS14 FADS1 EGFR NISCH FYN	3.25e-04	440	244	15	int:RND2
Interaction	KNL1 interactions	BUB1B NLE1 PML DCAF12 RBBP7 VIRMA DUSP16	3.27e-04	107	244	7	int:KNL1
Interaction	OFD1 interactions	WASHC2A BICD1 LONP1 PYGL WDR90 MRE11 VIRMA TBC1D31 DUSP16 NINL ELL DRC3 NIN	3.33e-04	347	244	13	int:OFD1
Interaction	IVNS1ABP interactions	GTF3C4 FANCD2 SYNE2 USP15 VIRMA LRPPRC VPS35 FYN ELL	3.58e-04	180	244	9	int:IVNS1ABP
Interaction	RAB9A interactions	WASHC2A FANCD2 RAB9A FAF2 SYNE2 ATP13A3 WASHC2C RALGAPB ARFGEF2 ATP9A VIRMA ARHGAP1 NBAS VAC14 EGFR NISCH PDCD11 ZFYVE26	3.59e-04	595	244	18	int:RAB9A
Interaction	LGR4 interactions	FASN NPC1L1 NUMA1 LAMC1 CPT1A VIRMA LRPPRC NISCH TLR2 PDCD11 AQR	3.69e-04	262	244	11	int:LGR4
Interaction	DNAJB11 interactions	UBR1 STUB1 FANCD2 LONP1 FASN MOGS ERAP2 NUCB1 NUMA1 LAMC1 VIRMA EGFR PAXIP1	3.72e-04	351	244	13	int:DNAJB11
Interaction	EIF4E interactions	STUB1 GART POLA2 DDX1 PML NFKBIZ AHSA1 DICER1 LRPPRC EGFR	3.78e-04	221	244	10	int:EIF4E
Interaction	GIGYF2 interactions	DDX1 BICD1 PHB1 FANCD2 FASN VIRMA EGFR DUSP16 KCTD3 NINL NIN	3.81e-04	263	244	11	int:GIGYF2
GeneFamily	WD repeat domain containing	IFT140 NLE1 WDR90 HERC1 DCAF12 RBBP7 DNAI3 SCAP TBC1D31 GTF3C2 PAFAH1B1 MAPKBP1	6.77e-06	262	169	12	362
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	WASF3 KDM3B TRIP12 BICD1 SYNE2 BUB1B ATP13A3 USP15 MRTFA LAMC1 AP3B1 DICER1 AZIN1 NBAS IBTK LRPPRC SETD2 TBC1D31 GTF3C2 EGFR PAFAH1B1 ITSN2 MACF1 KAT6B FYN AQR	1.90e-07	856	248	26	M4500
Coexpression	CAIRO_HEPATOBLASTOMA_CLASSES_UP	GART RPS14 DDX1 PHB1 DNAAF5 TCERG1 BUB1B NLE1 PYGL CDCA4 MRE11 ABCF2 CCT2 LRPPRC TBC1D31 GTF3C2 PAXIP1 PDCD11 TGS1	6.67e-06	612	248	19	M4772
Coexpression	FISCHER_DIRECT_P53_TARGETS_META_ANALYSIS	TM7SF3 SERPINB5 USP15 PML RALGAPB ARFGEF2 DNAI3 RGS16 CYFIP2 ZNF37A VCAN TLR3 TGS1	9.35e-06	311	248	13	M61
Coexpression	NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP	KCTD12 INTS1 KDM3B WASHC2A ERBIN MAP3K5 CLCN3 ERAP2 SYNE2 NIPA2 ATP13A3 USP15 WASHC2C MTERF3 NUMA1 ARFGEF2 LAMC1 CCT2 DICER1 CYFIP2 MMRN1 GLMN IBTK LRPPRC PAFAH1B1 PAXIP1 MACF1 FYN	1.36e-05	1215	248	28	M41122
Coexpression	GSE19888_ADENOSINE_A3R_INH_VS_ACT_IN_MAST_CELL_DN	RAB9B ZGRF1 GREB1L ZNF469 NFATC1 LMNTD1 XDH TG MMRN1 SERPINA10	2.15e-05	199	248	10	M7341
Coexpression	GSE5589_IL6_KO_VS_IL10_KO_LPS_STIM_MACROPHAGE_45MIN_UP	KDM3B MAP3K5 FASN WDR90 ABCG2 USP15 MAN1C1 LAMC1 ARHGAP1 ZFYVE26	2.24e-05	200	248	10	M6653
Coexpression	DE_YY1_TARGETS_DN	ERBIN ANGPT1 NUMA1 EGFR PAFAH1B1 MACF1 EPHA3	2.96e-05	93	248	7	M3278
CoexpressionAtlas	facebase_RNAseq_e9.5_MandArch_2500_K3	IFT140 WASF3 GART INTS1 GTF3C4 FREM1 PHB1 GREB1L FANCD2 DNAAF5 FASN MOGS CEP78 TCERG1 NFATC1 BUB1B NLE1 HOMER3 MRE11 DPY19L1 SLC35C2 NLRP1 ABCF2 RRP8 CPT1B DICER1 MMRN1 GLMN VAC14 SSU72 PUS10 NINL PDCD11 GPSM1	2.83e-06	1259	243	34	facebase_RNAseq_e9.5_MandArch_2500_K3
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	VWA5B2 ANKUB1 RHPN1 SYNE2 KCNN3 WDR90 CPLANE1 LMNTD1 VWA3A DNAI3 DRC3	1.65e-08	197	250	11	74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FREM1 PTPRZ1 KCNMA1 TRPM8 VWA3A MROH2A CPS1 SLC12A1 SPHKAP	3.18e-07	160	250	9	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FREM1 PTPRZ1 KCNMA1 TRPM8 VWA3A MROH2A CPS1 SLC12A1 SPHKAP	3.18e-07	160	250	9	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	mild_COVID-19_(asymptomatic)-RBC\|World / disease group, cell group and cell class (v2)	CHIC1 FANCD2 FANCB ALAS2 DCAF12 VIRMA RGS16 RGS14 HBB	5.04e-07	169	250	9	2bda6ab3f32e05cb7daf91eb7c39b4fcc9ae91bb
ToppCell	mild_COVID-19_(asymptomatic)-RBC\|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2)	CHIC1 FANCD2 FANCB ALAS2 DCAF12 VIRMA RGS16 RGS14 HBB	5.56e-07	171	250	9	78491478ba65bad45238fe114f5251b2adea323d
ToppCell	(05)_Ciliated-(4)_1wkpi\|(05)_Ciliated / shred by cell type and Timepoint	MORC1 B3GNT4 LCA5L SERPINB5 MRE11 MUC13 FADS1 KCTD3 MAPKBP1	8.55e-07	180	250	9	85fc9b164147b28545e2397d32302eea03ef6346
ToppCell	Calu_3-infected\|Calu_3 / Cell line, Condition and Strain	IFIT5 TRIP12 ERAP2 SYNE2 PML OAS2 NFKBIZ PPM1K SETD2	9.81e-07	183	250	9	8f7f5000645f24f20a8d7700c4df1f8953a1780b
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MAP3K5 COL6A3 ANGPT1 DNAI3 RGS16 FADS1 VCAN PAPPA MYO16	1.34e-06	190	250	9	45df8fee00f8949937863159d7aa042e72748d9b
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KCTD12 FREM1 COL6A3 ANGPT1 RGS16 PAPPA GSG1L LUM MYO16	1.34e-06	190	250	9	d60395739458d7f47a3350ade751fe3819500320
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive\|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	CAB39 HAVCR1 NFATC1 ATP13A3 MRTFA NFKBIZ EGFR MACF1 FYN	1.46e-06	192	250	9	8b86db2ebe0199fee0e9800566a619a24bfdeed5
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lmo1_Myl1\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	FREM1 PTPRZ1 VIP ANGPT1 MROH2A RGS16 EGFR EPHA3	1.68e-06	145	250	8	590ba937c741ae67460f303eca88b1cd3ac87f64
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-2M-IPC_like-IPs_and_early_cortical_neurons\|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type.	BICD1 PTPRZ1 SYNE2 DPY19L1 LAMC1 RGS16 KAT6B FYN SEZ6	1.88e-06	198	250	9	7943e4f67c3d6efb5c8b00aa0ff3cfe7be10c48d
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-2M-IPC_like\|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type.	BICD1 PTPRZ1 SYNE2 DPY19L1 LAMC1 RGS16 KAT6B FYN SEZ6	1.88e-06	198	250	9	6d12ecaa9532c134d9c4562534dcb59a6420b4d3
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	MAP3K5 FASN ATP13A3 COL6A3 ANGPT1 DNAI3 VCAN PAPPA MYO16	1.96e-06	199	250	9	8b86c69aaf60feff53aa782559cfece7342a23de
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|Control_saline / Treatment groups by lineage, cell group, cell type	FREM1 COL6A3 ANGPT1 LAMC1 DNAI3 VCAN MACF1 LUM MYO16	2.05e-06	200	250	9	bd8cf33502adea320e91ca2af14e1911d88ad374
ToppCell	Control-Epithelial_alveolar-AT_2-Differentiating_AT1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FANCB ERAP2 PYGL MRE11 SLC9A8 PPM1K SCAP AP3B2	3.04e-06	157	250	8	4766f7d545bf2d775390589460677519cb92f4d5
ToppCell	droplet-Liver-HEPATOCYTES-1m-Epithelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GCGR FASN PYGL GPLD1 APOB RGS16 EGFR SERPINA10	5.03e-06	168	250	8	b98af4043dfa5dfa4413e482879fad88de484675
ToppCell	droplet-Liver-HEPATOCYTES-1m-Epithelial-hepatocyte\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GCGR FASN PYGL GPLD1 APOB RGS16 EGFR SERPINA10	5.03e-06	168	250	8	073b53d4cee6bc8c5c6fce51cf6cd9c316478f69
ToppCell	droplet-Liver-HEPATOCYTES\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GCGR FASN PYGL GPLD1 APOB RGS16 EGFR SERPINA10	5.25e-06	169	250	8	f195467438c589f87224bde7da720dea072d110c
ToppCell	droplet-Liver-HEPATOCYTES-1m\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GCGR FASN PYGL GPLD1 APOB RGS16 EGFR SERPINA10	5.25e-06	169	250	8	7785cab967a33560830c394c918d6ce625103858
ToppCell	PND14-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MORC1 B3GNT4 ZNF469 CCNA1 C10orf67 DNAI3 TBC1D31 DRC3	8.34e-06	180	250	8	5c9d2d44d840cd4ec7d42d43446ba2b689e7ec43
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	KCTD12 C3orf70 VIP ANGPT1 RGS16 EGFR VCAN SEZ6	8.34e-06	180	250	8	c6030e725e3d86d5d74a1676330c77ffeceb324f
ToppCell	PND14-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal-Deuterosomal_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MORC1 B3GNT4 ZNF469 CCNA1 C10orf67 DNAI3 TBC1D31 DRC3	8.34e-06	180	250	8	c60e74fbbd815a0251253a19dc520a254b2e1762
ToppCell	droplet-Fat-Gat-18m-Mesenchymal-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GREB1L KCNMA1 SEC16B COL6A3 SLF1 ANGPT1 ZFYVE26	9.82e-06	132	250	7	4152529611eeacf0c547e2a134d5b98c45426b13
ToppCell	wk_15-18-Hematologic-Myeloid-Basophil\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	TRPM6 CCPG1 CCNA1 USP15 MRTFA OAS2 RAB44 ITSN2	1.14e-05	188	250	8	3638d85452de15a060146628fbbad9d2a36feb13
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PTPRZ1 C3orf70 VIP ANGPT1 RGS16 EGFR VCAN SEZ6	1.14e-05	188	250	8	c66fccdfe68760b8c3efca77e3c25966dc9a8a5f
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	SYNE2 HERC1 USP15 COL6A3 NFKBIZ NLRP1 MACF1 FYN	1.33e-05	192	250	8	47646d7e4990be85072987f92bf18d52f8da752e
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CCPG1 C1QTNF6 COL6A3 B3GNT9 LAMC1 EGFR VCAN LUM	1.33e-05	192	250	8	beac6b3c191b11add8e39e8d04562b478ea8929e
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A3 ANGPT1 RGS16 FADS1 PAPPA GSG1L LUM MYO16	1.33e-05	192	250	8	ee085e04d5dcfb657522484ed20b8c1ddeccfe0c
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	ATP13A3 MRTFA NUCB1 NFKBIZ AHSA1 DUSP16 IFFO2 ELL	1.33e-05	192	250	8	3f925a80b5e2b0577d573e88598a2984a5f6a789
ToppCell	RV-01._Fibroblast_I\|RV / Chamber and Cluster_Paper	WASF3 COL6A3 LAMC1 NFKBIZ EGFR VCAN PAPPA FYN	1.33e-05	192	250	8	356160b113c3305a61ceeaff33ce3c9da0be2878
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A3 ANGPT1 DNAI3 RGS16 FADS1 PAPPA LUM MYO16	1.33e-05	192	250	8	f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b
ToppCell	LPS_only-Stromal_mesenchymal\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A3 ANGPT1 RGS16 FADS1 PAPPA GSG1L LUM MYO16	1.33e-05	192	250	8	162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	DCHS2 GC NPC1L1 GAPDHS DNAH8 MROH9 XDH GUCY2C	1.38e-05	193	250	8	315840bc48899f3a36d57b19197509de19716e3d
ToppCell	NS-moderate-d_0-4\|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ABCA13 ANKUB1 PTPRZ1 CPLANE1 VWA3A DNAI3 EGFR DRC3	1.38e-05	193	250	8	ea345d34440b25f65358a53dc72831998d1c3620
ToppCell	LV-01._Fibroblast_I\|LV / Chamber and Cluster_Paper	WASF3 COL6A3 LAMC1 NFKBIZ EGFR VCAN PAPPA FYN	1.38e-05	193	250	8	dc17f3b9758936d428cf17f77a1ce6d4c479b165
ToppCell	RV-02._Fibroblast_II\|RV / Chamber and Cluster_Paper	MRTFA COL6A3 LAMC1 NFKBIZ EGFR VCAN PAPPA FYN	1.44e-05	194	250	8	11c79a8c56ece42713b04b321982e41e239f07a5
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	RPS14 FREM1 COL6A3 ANGPT1 SPHKAP VCAN LUM EPHA3	1.44e-05	194	250	8	a3e5a15cf6c1361207f661ee15eb634f77daf1cb
ToppCell	RV-02._Fibroblast_II\|World / Chamber and Cluster_Paper	MRTFA COL6A3 LAMC1 NFKBIZ EGFR VCAN PAPPA FYN	1.49e-05	195	250	8	ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	FREM1 COL6A3 ANGPT1 DNAI3 MACF1 PAPPA LUM MYO16	1.61e-05	197	250	8	fdb92985f7df0c280b87d3e43c2394e70786a2c7
ToppCell	10x3'2.3-week_17-19-Mesenchymal_adipo\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	WASF3 MMP13 COL6A3 ANGPT1 EGFR VCAN PAPPA LUM	1.61e-05	197	250	8	5afddde4e2b5cd55abe11e9b9efae02dbdc3da3a
ToppCell	10x3'2.3-week_17-19-Mesenchymal_adipo-stroma\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	WASF3 MMP13 COL6A3 ANGPT1 EGFR VCAN PAPPA LUM	1.61e-05	197	250	8	b9745e382baa2725dfcae060701fb53f6c8a31fa
ToppCell	10x3'2.3-week_17-19-Mesenchymal_adipo-stroma-adipo-CAR\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	WASF3 MMP13 COL6A3 ANGPT1 EGFR VCAN PAPPA LUM	1.61e-05	197	250	8	1baffd087ca194a7355fefbb3bf67befb14fe2de
ToppCell	IPF-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	KCTD12 BICD1 COL6A3 ANGPT1 VCAN MACF1 LUM EPHA3	1.61e-05	197	250	8	f304d42fc4936fe20996e07c8dccc698a6e5e5ef
ToppCell	LPS_only-Epithelial_airway-airway_epithelial-Ciliated\|LPS_only / Treatment groups by lineage, cell group, cell type	RHPN1 LMNTD1 VWA3A C10orf67 GALNT12 DNAI3 DNAH1 DRC3	1.66e-05	198	250	8	6d90b541fde357fbb40f8f7d4e8628a48b679718
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB\|Control_saline / Treatment groups by lineage, cell group, cell type	FREM1 COL6A3 B3GNT9 ANGPT1 VCAN MACF1 LUM MYO16	1.73e-05	199	250	8	c2c42ecf20d1924edc2f899c01dfa5fcf3c210b9
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	FREM1 COL6A3 ANGPT1 DNAI3 VCAN MACF1 LUM MYO16	1.73e-05	199	250	8	a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	FREM1 COL6A3 ANGPT1 LAMC1 VCAN MACF1 LUM MYO16	1.73e-05	199	250	8	30d3e8c0681ec11f86dd38c5f48d21187a1b4f90
ToppCell	Control-B_intermediate-1\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	WASHC2A ERBIN CPLANE1 MRE11 SLF1 WASHC2C AZIN1	1.73e-05	144	250	7	984470ff6ddce4c743e2db78fa98dae055aaa273
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	FREM1 COL6A3 ANGPT1 LAMC1 VCAN MACF1 LUM MYO16	1.79e-05	200	250	8	9b0916d8d07ac2bf1739f7be5296bf77ffee6094
ToppCell	Control_saline-Mesenchymal_fibroblastic\|Control_saline / Treatment groups by lineage, cell group, cell type	FREM1 COL6A3 B3GNT9 ANGPT1 VCAN MACF1 LUM MYO16	1.79e-05	200	250	8	64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-Unfolded_protein_responsible_cell\|6m / Sample Type, Dataset, Time_group, and Cell type.	ANO9 POF1B NPC1L1 SLC26A3 XDH APOB MUC13 GUCY2C	1.79e-05	200	250	8	12078bc25be67180c0f4b37fef921cdcd1003576
ToppCell	Lung_Parenchyma-Severe-Hematopoietic\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	PKDREJ BUB1B ALAS2 DCAF12 COL6A3 HBD LUM HBB	1.79e-05	200	250	8	fdf3e60cf94f398a56c0fa72813d0459f5ce081b
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TRIP12 SYNE2 USP15 OAS2 NFKBIZ SETD2 ITSN2 MACF1	1.79e-05	200	250	8	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	LPS_IL1RA-Hematopoietic_Myeloid-Granulocytic_cells-Neutrophils\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	PYGL ATP13A3 SEMA4A FMNL1 AZIN1 TG VCAN TLR2	1.79e-05	200	250	8	fd1b6db3c62f5a205b769ba0e61433dae6285b67
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_only / Treatment groups by lineage, cell group, cell type	FREM1 COL6A3 ANGPT1 DNAI3 VCAN MACF1 LUM MYO16	1.79e-05	200	250	8	a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2
ToppCell	Parenchyma_COVID-19-Stromal-TX-Erythrocytes\|Parenchyma_COVID-19 / Sample group, Lineage and Cell type	PKDREJ BUB1B ALAS2 DCAF12 COL6A3 HBD LUM HBB	1.79e-05	200	250	8	a9edac2f5e009662df452ec032a80e855cdac28f
ToppCell	Lung_Parenchyma-Severe-Hematopoietic-RBC-RBC\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	PKDREJ BUB1B ALAS2 DCAF12 COL6A3 HBD LUM HBB	1.79e-05	200	250	8	b5f2892bc45fda5ae05e269b840305a608a07c37
ToppCell	Lung_Parenchyma-Severe-Hematopoietic-RBC\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	PKDREJ BUB1B ALAS2 DCAF12 COL6A3 HBD LUM HBB	1.79e-05	200	250	8	9ce1f91991637fc3af0f6a80a85e1a44276fe412
ToppCell	Lung_Parenchyma-Severe-Hematopoietic-RBC-RBC-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PKDREJ BUB1B ALAS2 DCAF12 COL6A3 HBD LUM HBB	1.79e-05	200	250	8	199165be1aef8497af71b74690a11de18fbe073c
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts\|Control_saline / Treatment groups by lineage, cell group, cell type	FREM1 COL6A3 B3GNT9 ANGPT1 VCAN MACF1 LUM MYO16	1.79e-05	200	250	8	a1fc74c1b27e104895910bc7cdce7ba33d30df7e
ToppCell	LPS_IL1RA-Hematopoietic_Myeloid-Granulocytic_cells\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	PYGL ATP13A3 SEMA4A FMNL1 AZIN1 TG VCAN TLR2	1.79e-05	200	250	8	0b7573ec4e9c67c7d11dd8f5011a70bade30e930
ToppCell	MS-CD4-antiviral_CD4\|MS / Condition, Cell_class and T cell subcluster	IFIT5 SYNE2 VWA3A OAS2 PPM1K TG SERPINA10	2.45e-05	152	250	7	b1eba2d5a6da3eeb83d40a92976e3e8751ed18ee
ToppCell	P07-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	VWA5B2 WIPF3 MAP3K5 MRTFA PPM1K DNAH1 EPHA3	2.56e-05	153	250	7	5501095bcf73080872ae01128f21399f9cfc5dd1
ToppCell	Fetal_29-31_weeks-Immune-dendritic_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ZP2 PDILT DHTKD1 FMNL1 CYFIP2 TLR3 NIN	2.78e-05	155	250	7	9f937ae48767fdcf1a944af4de0530d9c0ab441d
ToppCell	facs-Liver-Non-hepatocytes-3m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VWA5B2 MORC1 LMNTD1 SLC26A3 MMRN1 SPHKAP AP3B2	2.78e-05	155	250	7	8fdda4e3657ac56188ae88ed3caf145f4d9d1567
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DCHS2 LCA5L FREM1 KCNN3 LMNTD1 COL6A3 NFKBIZ	3.02e-05	157	250	7	beab0ac47202266b04543c02cfcdda012375e879
ToppCell	droplet-Liver-HEPATOCYTES-1m-Epithelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GC GCGR FASN PYGL GPLD1 APOB RGS16	3.14e-05	158	250	7	9f58428f70d1427b20122c5c1cc7bf521d0f4832
ToppCell	Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Fibcd1-Excitatory_Neuron.Slc17a7.FIbcd1-Inhba_(CA1_Principal_cells)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	NPC1L1 C10orf67 TNNI3K TRIM69 GUCY2C	3.20e-05	65	250	5	5fc678ea0490cbcfe00d569727b97ccba3a19232
ToppCell	Basal_cells-IPF_04\|World / lung cells shred on cell class, cell subclass, sample id	TRPM6 ABCA13 SERPINB5 PTPRZ1 PCDHGA9 MAN1C1 APOB	3.83e-05	163	250	7	679e25e5548d157d49a73057a3b5617dccda260f
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Serpinf1-Serpinf1_Aqp5_Vip\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	KCTD12 VIP NFKBIZ BPIFB6 RGS16 EGFR	3.86e-05	111	250	6	84b7d4fe5839f649bc4246738d620c9cee3c4cf7
ToppCell	Control-B_intermediate-1\|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5)	WASHC2A ERBIN CPLANE1 MRE11 SLF1 WASHC2C AZIN1	4.47e-05	167	250	7	948504367ecf58144d9dd74d2ec531358fc4b309
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	BCS1L RHPN1 PDILT MUC13 DNAI3 DNAH1 ERMARD	4.65e-05	168	250	7	9a8709d34865cfa668d8f3335dc34fc86fc32482
ToppCell	5'-Adult-Appendix-Hematopoietic-T_cells-TRGV2_gdT\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ZNF354C GPLD1 NLRP1 DNAI3 KAT6B ERMARD FYN	4.82e-05	169	250	7	8caf7996796a2e2716e3855de855c903d6126bf2
ToppCell	PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ADGRB2 FANCD2 COL6A3 B3GNT9 VCAN MYO16 EPHA3	4.82e-05	169	250	7	335619507857383c3b0b507cdf05d786ed59e585
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Ptprt_Pkp2\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	GCGR PTPRZ1 C3orf70 VIP ANGPT1 EGFR SEZ6	5.01e-05	170	250	7	14aa86a4f526ed6986afcb28c49225522055550c
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ZGRF1 ADGRB2 FANCB BUB1B COL6A3 VCAN EPHA3	5.20e-05	171	250	7	b0373ed8283ee1792b6a490bff93906546978593
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ZGRF1 ADGRB2 FANCB BUB1B COL6A3 VCAN EPHA3	5.20e-05	171	250	7	b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-I_cells_(CCK+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VWA5B2 GC ADGRG4 CCNA1 TTC24 GSG1L SEZ6	5.39e-05	172	250	7	2651dece87c3e3d2d6370f5274ebae357474b825
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Vip\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	KCTD12 PTPRZ1 VIP ANGPT1 RGS16 EGFR SEZ6	5.39e-05	172	250	7	7e1a7700a4c2b1d100da1d6e475e73498ebb605a
ToppCell	3'-Child04-06-SmallIntestine-Epithelial-neuro-epithelial\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VWA5B2 KCTD12 GC ADGRG4 GUCY2C SERPINA10 GSG1L	5.59e-05	173	250	7	07798461d12d04f3dabff03481c999cb07c5af2f
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Chat_Htr1f\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	KCTD12 PTPRZ1 VIP NFKBIZ RGS16 EGFR SEZ6	5.80e-05	174	250	7	a5f2a4e3b25e6084bd7003a53da86a44f6fcf294
ToppCell	droplet-Lung-21m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-proliferating_NK\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ZGRF1 ADGRB2 BICD1 BUB1B WDR90 MRE11 TBC1D31	6.01e-05	175	250	7	6751ee4b312d7f87275f2c35e5878cfc3be3ebe3
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Ptprt_Pkp2\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	GCGR PTPRZ1 C3orf70 VIP ANGPT1 EGFR SEZ6	6.23e-05	176	250	7	05ec715439f2eb1696f5d8855da0dd1dd70effd0
ToppCell	3'-Pediatric_IBD-SmallIntestine-Epithelial-neuro-epithelial\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VWA5B2 KCTD12 GC ADGRG4 GUCY2C SERPINA10 GSG1L	6.23e-05	176	250	7	fb718a6b07aa5d56600263280afa530bcb63db42
ToppCell	(2)_unknow\|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)	ALAS2 ABCG2 DCAF12 FREM3 HBB HBD	6.25e-05	121	250	6	0090aef3d8a42968828edc637773ef99b2940dde
ToppCell	(2)_Unknown\|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)	ALAS2 ABCG2 DCAF12 FREM3 HBB HBD	6.25e-05	121	250	6	6689c9016f29ce6a16824614b6229a71c42babb5
ToppCell	PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	BICD1 BUB1B SEMA4A SLC26A3 PUS10 TLR2 ZFYVE26	6.46e-05	177	250	7	1d5a071157c755f3a27a5c3143015da04ee0b0dc
ToppCell	droplet-Spleen-SPLEEN-30m-Hematologic-proerythroblast\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BUB1B PYGL GPLD1 XDH MUC13 RAB44 VCAN	6.69e-05	178	250	7	be8af4d85b8835a85a168639c37857dcaa6b00bf
ToppCell	TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7\|TCGA-Colorectal / Sample_Type by Project: Shred V9	SLC9A8 RALGAPB ARFGEF2 LAMC1 ATP9A VCAN EPHA3	6.69e-05	178	250	7	edc76b8f15056ec1c9a1c61a048b6331a92592d6
ToppCell	3'-Pediatric_IBD-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VWA5B2 KCTD12 GC ADGRG4 ATP9A GUCY2C SERPINA10	6.93e-05	179	250	7	f2e8fc975c30992611630197b79daaeef7c4211d
ToppCell	5'-Adult-Appendix-Hematopoietic-Myeloid-LYVE1+_Macrophage\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FANCB ALKBH1 ZNF469 KCNMA1 SEMA4A VCAN TLR2	7.18e-05	180	250	7	66c7b02d85e32ba3e7530d0c4aff17e7525ccdd8
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FREM1 GREB1L ANGPT1 EGFR SPHKAP LUM MYO16	7.43e-05	181	250	7	03a303cd2f366f09c18b118bbba6f5e3f95ad56c
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	KCNN3 COL6A3 LAMC1 VCAN PAPPA LUM EPHA3	7.70e-05	182	250	7	3dfa9187e9d2bab1d199079d29209c4648220ada
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MAP3K5 GREB1L ZNF469 KCNN3 VWA3A KCNG3 GSG1L	7.96e-05	183	250	7	1645d4a55cd8c22d6eb47fc5c6b1e576c454f111
ToppCell	COVID-19_Mild-NK_activated\|COVID-19_Mild / Disease condition and Cell class	WASHC2A ERBIN CPLANE1 WASHC2C OAS2 VIRMA MACF1	7.96e-05	183	250	7	22bd05135906d0ecc4ba8c2e0a666093d1bf3b8f
ToppCell	Control-Epithelial_alveolar-Mes-Like-Differentiating_AT1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PTPRZ1 LMNTD1 VWA3A RAB44 AP3B2 DRC3	8.18e-05	127	250	6	556aaf88719c83f307fa50dfac151136ed05c8ad
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA13 FREM1 MROH2A APOB CPS1 DNAH1 MYO16	8.24e-05	184	250	7	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MAP3K5 ZNF469 KCNN3 VWA3A MAN1C1 KCNG3 FREM3	8.24e-05	184	250	7	34e316ad8e7b8667cd8ad61397281802a252744f
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA13 FREM1 MROH2A APOB CPS1 DNAH1 MYO16	8.24e-05	184	250	7	2b19a8c5f823e00812908b23e66bb4e563278aff
Drug	AC1L3NLD	FASN PYGL APOB CPT1A CPT1B CPT2	6.20e-07	29	249	6	CID000092184
Drug	Bisacodyl [603-50-9]; Down 200; 11uM; PC3; HT_HG-U133A	IFIT5 MAP3K5 ERAP2 CCNA1 USP15 HOMER3 MRTFA OAS2 ABCF2 CPS1 PAFAH1B1 TGS1	1.54e-06	193	249	12	4616_DN
Drug	etomoxiryl-CoA	FASN CPT1A CPT1B CPT2	6.45e-06	12	249	4	CID003081714
Drug	POCA	FANCB FASN CPT1A CPT1B CPT2	8.19e-06	26	249	5	CID000054217
Drug	4-Cphoc	VIP CPT1A CPT1B CPT2	9.24e-06	13	249	4	CID000001230
Drug	AC1L1FF5	FANCB FASN AKR1B10 KCNMA1 APOB CPT1A CPT1B CPT2 FADS1 FYN	9.37e-06	157	249	10	CID000003209
Drug	To 2	MAP3K5 SGCB APOB SLC12A1 HBB HBD MYBPC3	1.04e-05	69	249	7	CID000084102
Drug	TDGA-carnitine	CPT1A CPT1B CPT2	1.27e-05	5	249	3	CID000196388
Drug	4 t ha	CPT1A CPT1B CPT2	1.27e-05	5	249	3	CID000124503
Drug	bezafibroyl CoA	CPT1A CPT1B CPT2	1.27e-05	5	249	3	CID000176137
Drug	ciprofibrate	FANCB AKR1B10 TONSL APOB CPT1A CPT1B CPT2 FLAD1 KAT6B TGS1	1.88e-05	170	249	10	CID000002763
Drug	glibenclamide	ABCA13 CLCN3 KCNMA1 KCNN3 ABCG2 VIP SGCB ABCF2 APOB CPT1A CPT1B CPT2 GUCY2C HBB HBD	2.23e-05	382	249	15	CID000003488
Drug	TG-CoA	CPT1A CPT1B CPT2	2.52e-05	6	249	3	CID000124781
Drug	FOX 988	CPT1A CPT1B CPT2	2.52e-05	6	249	3	CID005491458
Drug	PDCoA	CPT1A CPT1B CPT2	2.52e-05	6	249	3	CID000125034
Drug	pisolithin A	CPT1A CPT1B CPT2	2.52e-05	6	249	3	CID000000355
Drug	heme b	FANCD2 EIF2B2 TONSL KCNMA1 ALAS2 ABCG2 GAPDHS SGCB PPM1K VIRMA SETD2 GUCY2C AP3B2 HBB HBD AQR	3.38e-05	444	249	16	CID000004973
Drug	NSC302991	CAB39 PKDREJ MAP3K5 PHB1 FANCD2 BUB1B ABCG2 PML GPLD1 MRE11 ATG7 NUMA1 ABCF2 CPT2	3.76e-05	353	249	14	CID000002538
Drug	buformin	GAPDHS CPT1A CPT1B CPT2	3.79e-05	18	249	4	CID000002468
Drug	HBBA	GC HBB HBD	4.38e-05	7	249	3	CID016072199
Drug	Beclomethasone dipropionate [5534-09-8]; Up 200; 7.6uM; PC3; HT_HG-U133A	KCNMA1 NLE1 CPLANE1 PML NLRP1 TG EGFR VCAN TLR2 TGS1	5.08e-05	191	249	10	4580_UP
Drug	nitric oxide	GC MAP3K5 FANCD2 AKR1B10 TONSL KCNMA1 KCNN3 GAPDHS MMP13 GPLD1 VIP SLC26A3 ANGPT1 SGCB XDH NFKBIZ NLRP1 SETD2 SLC12A1 EGFR GUCY2C VCAN TLR2 TLR3 KAT6B HBB HBD	5.30e-05	1075	249	27	CID000145068
Drug	Methylergometrine maleate [113-42-8]; Down 200; 8.8uM; PC3; HT_HG-U133A	ERAP2 MMP13 HOMER3 NUMA1 GALNT12 DICER1 ARHGAP1 RGS14 FYN TGS1	5.54e-05	193	249	10	6704_DN
Drug	2-propylpentanoic acid; Down 200; 1000uM; PC3; HG-U133A	NLE1 NIPA2 PML SLC35C2 NUMA1 ABCF2 RRP8 GLMN EGFR KAT6B	5.79e-05	194	249	10	433_DN
Drug	Finasteride [98319-26-7]; Down 200; 10.8uM; HL60; HT_HG-U133A	IFT140 ERAP2 HOMER3 MRTFA ANGPT1 SGCB NLRP1 CYFIP2 RGS14 ZFYVE26	5.79e-05	194	249	10	2206_DN
Drug	Nalbuphine hydrochloride [23277-43-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A	NLE1 HOMER3 PML SLC9A8 NUMA1 XDH CPT2 TLR2 AQR EPHA3	6.31e-05	196	249	10	2225_DN
Drug	AC1L1G3W	MAP3K5 HAVCR1 TONSL GAPDHS SGCB XDH NLRP1 SETD2 GUCY2C HBB HBD	6.43e-05	237	249	11	CID000003514
Drug	(+) -Levobunolol hydrochloride [47141-41-3]; Down 200; 12.2uM; HL60; HT_HG-U133A	PML MAN1C1 NUMA1 NLRP1 CPT1A CYFIP2 ARHGAP1 RGS14 ZFYVE26 EPHA3	6.87e-05	198	249	10	3016_DN
Drug	Fursultiamine Hydrochloride [2105-43-3]; Up 200; 9.2uM; PC3; HT_HG-U133A	BICD1 NLE1 ABCG2 PML GPLD1 XDH NLRP1 CPT1B PAPPA DRC3	6.87e-05	198	249	10	6630_UP
Drug	AC1O5S5Y	CPT1A CPT1B CPT2	6.95e-05	8	249	3	CID006439672
Drug	AC1L2B9U	STUB1 HBB HBD	6.95e-05	8	249	3	CID000044164
Drug	AD-143	POLA2 CPT1A CPT2	6.95e-05	8	249	3	CID000333663
Drug	methylthiopropionylcarnitine	CPT1A CPT1B CPT2	6.95e-05	8	249	3	CID000194919
Drug	Verteporfin [129497-78-5]; Down 200; 2.8uM; HL60; HT_HG-U133A	CLCN3 MOGS ERAP2 SEMA4A SLC9A8 LAMC1 VCAN TLR2 MACF1	6.96e-05	160	249	9	6133_DN
Drug	S-nitrosocysteine	MAP3K5 NFATC1 KCNMA1 SGCB GUCY2C HBB HBD	7.32e-05	93	249	7	CID003359494
Drug	epicholesterol	FANCB FASN RAB9A NPC1L1 TONSL KCNMA1 PML COL6A3 APOB CPT1A SCAP EGFR GUCY2C PAFAH1B1 TLR2 TLR3 HBB HBD MYBPC3	8.00e-05	636	249	19	CID000000304
Drug	L-NNA	KCNMA1 KCNN3 VIP SGCB NLRP1 CPT1A CPT1B CPT2 GUCY2C HBB HBD	8.34e-05	244	249	11	CID000004367
Drug	CoA group	GTF3C4 FASN NPC1L1 KCNMA1 ALAS2 GAPDHS DHTKD1 APOB CPS1 CPT1A CPT1B CPT2 SCAP KAT6B MYBPC3	9.23e-05	433	249	15	CID000000317
Drug	3-acetamido-4-trimethylaminobutyric acid	CPT1A CPT1B CPT2	1.03e-04	9	249	3	CID000127169
Drug	sodium linoleate	FANCD2 FANCB FASN TONSL KCNMA1 PML APOB CPT1A CPT1B CPT2 FADS1 EGFR FLAD1	1.09e-04	342	249	13	CID000003931
Drug	DL-arginine	GC FANCD2 GAPDHS VIP SGCB XDH CPS1 SETD2 SLC12A1 APPL2 GUCY2C HBB HBD	1.15e-04	344	249	13	CID000000232
Drug	tricapryl(methyl)ammonium	HBB HBD	1.19e-04	2	249	2	CID011071504
Drug	allyl 2,4,6-tribromophenyl ether	HBB HBD	1.19e-04	2	249	2	CID000076767
Drug	Phleomycin E	KCNMA1 NUCB1	1.19e-04	2	249	2	CID000159334
Drug	1,3,5-tribromobenzene	HBB HBD	1.19e-04	2	249	2	CID000012279
Drug	2-(alpha-hydroxybenzyl)-benzimidazole	HBB HBD	1.19e-04	2	249	2	CID000005792
Drug	NSC-334295	HBB HBD	1.19e-04	2	249	2	CID000100107
Drug	Perhexiline	CPT1A CPT2	1.19e-04	2	249	2	DB01074
Drug	AC1L3OJQ	HBB HBD	1.19e-04	2	249	2	CID000119294
Drug	pentabromobenzene	HBB HBD	1.19e-04	2	249	2	CID000011854
Drug	tribromobenzene	HBB HBD	1.19e-04	2	249	2	CID000011842
Drug	Bromkal 73-5 PE	HBB HBD	1.19e-04	2	249	2	CID000118216
Disease	Colorectal Carcinoma	ABCA13 IPP SERPINB5 NFATC1 AKR1B10 PDILT BUB1B ABCG2 DNAH8 LAMC1 GALNT12 APOB TNNI3K FADS1 EGFR GUCY2C PUS10 TLR2 EPHA3	6.60e-06	702	243	19	C0009402
Disease	anemia (biomarker_via_orthology)	ALAS2 HBB HBD	1.88e-05	7	243	3	DOID:2355 (biomarker_via_orthology)
Disease	Colorectal Neoplasms	ABCA13 IPP SERPINB5 AKR1B10 BUB1B ABCG2 GALNT12 FADS1 EGFR GUCY2C TLR2	2.09e-05	277	243	11	C0009404
Disease	Hereditary xanthinuria	MOCOS XDH	6.75e-05	2	243	2	cv:C5779508
Disease	thalamus volume	BICD1 OAS2 EGFR MACF1 PAPPA EPHA3	7.45e-05	85	243	6	EFO_0006935
Disease	Malignant Neoplasms	FASN AKR1B10 MRE11 DICER1 SETD2 EGFR EPHA3	9.56e-05	128	243	7	C0006826
Disease	cortical thickness	VWA5B2 TM7SF3 ZNF469 PMPCA PKD1 USP15 ANGPT1 ARFGEF2 LAMC1 GALNT12 RAB44 TG LMAN1L FADS1 EGFR VCAN PAFAH1B1 KCTD3 MACF1 MYO16 ELL EPHA3	1.47e-04	1113	243	22	EFO_0004840
Disease	beta thalassemia (implicated_via_orthology)	HBB HBD	2.02e-04	3	243	2	DOID:12241 (implicated_via_orthology)
Disease	Delta-Beta Thalassemia	HBB HBD	2.02e-04	3	243	2	C0271985
Disease	N-palmitoyl-sphinganine (d18:0/16:0) measurement	SYNE2 DCAF12	2.02e-04	3	243	2	EFO_0800428
Disease	brain measurement, neuroimaging measurement	VWA5B2 DCHS2 IPP ABCG2 SLF1 ANGPT1 LAMC1 GALNT12 TG EGFR VCAN MACF1 PAPPA EPHA3	2.08e-04	550	243	14	EFO_0004346, EFO_0004464
Disease	low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	HAVCR1 PMPCA SYNE2 APOB CPT1A DNAH1 FADS1 MACF1	2.68e-04	200	243	8	EFO_0004611, EFO_0020945
Disease	valine measurement	NFATC1 ABCG2 USP15 PPM1K	3.25e-04	40	243	4	EFO_0009792
Disease	eye disease (is_marker_for)	TLR2 TLR3	4.01e-04	4	243	2	DOID:5614 (is_marker_for)
Disease	colorectal cancer (is_implicated_in)	BUB1B GALNT12 DICER1 SETD2 EGFR TLR2	5.12e-04	121	243	6	DOID:9256 (is_implicated_in)
Disease	Adverse reaction to drug	GC HAVCR1 ABCG2 MOCOS TLR2	6.61e-04	84	243	5	C0041755
Disease	Drug toxicity	GC HAVCR1 ABCG2 MOCOS TLR2	6.61e-04	84	243	5	C0013221
Disease	Congenital absence of kidneys syndrome	FREM1 GREB1L	6.64e-04	5	243	2	C1609433
Disease	phosphatidylcholine (16:0/22:5n3, 18:1/20:4) measurement	CPT1A FADS1	6.64e-04	5	243	2	EFO_0800467
Disease	hemoglobin measurement, hemoglobin A2 measurement	HBD HBD	6.64e-04	5	243	2	EFO_0004509, EFO_0005845
Disease	very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	HAVCR1 PMPCA SYNE2 NPC1L1 APOB CPS1 CPT1A MACF1 MYBPC3	7.35e-04	291	243	9	EFO_0008317, EFO_0020946
Disease	urinary albumin to creatinine ratio	WIPF3 NUMA1 CCT2 CPS1 GTF3C2 SPHKAP HBB	7.37e-04	179	243	7	EFO_0007778
Disease	alkaline phosphatase measurement	STRA8 PMPCA NFATC1 EIF2B2 TONSL PKD1 PYGL DCAF12 GPLD1 SEC16B APOB CPS1 CPT1A AP3B1 AZIN1 FADS1 MACF1 GSG1L MYBPC3	8.03e-04	1015	243	19	EFO_0004533
Disease	level of Sphingomyelin (d40:2) in blood serum	GC SYNE2 FADS1	8.65e-04	23	243	3	OBA_2045181
Disease	Squamous cell carcinoma of the head and neck	CCNA1 ABCG2 TNNI3K EGFR	8.91e-04	52	243	4	C1168401
Disease	childhood onset asthma, age at onset, environmental tobacco smoke exposure measurement	PYGL NIN	9.91e-04	6	243	2	EFO_0004847, EFO_0008361, MONDO_0005405
Disease	hemoglobin E disease	HBD HBD	9.91e-04	6	243	2	MONDO_0016243
Disease	lipid metabolism disorder (is_implicated_in)	CPT1A CPT2	9.91e-04	6	243	2	DOID:3146 (is_implicated_in)
Disease	glucagon measurement, glucose tolerance test	HERC1 MACF1	9.91e-04	6	243	2	EFO_0004307, EFO_0008463
Disease	periventricular nodular heterotopia (is_implicated_in)	ARFGEF2 ERMARD	9.91e-04	6	243	2	DOID:0050454 (is_implicated_in)
Disease	Lissencephaly	PAFAH1B1 MACF1	9.91e-04	6	243	2	C0266463
Disease	albuminuria	WIPF3 CCT2 CPS1 SPHKAP MAPKBP1	1.10e-03	94	243	5	EFO_0004285
Disease	triacylglycerol 52:2 measurement	MRE11 TG FADS1 GTF3C2	1.10e-03	55	243	4	EFO_0010414
Disease	Schizophrenia	KCTD12 ABCA13 GC CSMD2 PHB1 PTPRZ1 KCNN3 PML VIP DICER1 ARHGAP1 PAFAH1B1 VPS35 TLR2 TLR3 FYN MYO16	1.11e-03	883	243	17	C0036341
Disease	Pancytopenia	FANCD2 FANCB MOCOS	1.25e-03	26	243	3	C0030312
Disease	cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement	SYNE2 NPC1L1 APOB CPS1 CPT1A MACF1	1.27e-03	144	243	6	EFO_0004611, EFO_0020943
Disease	Hyperuricemia	ABCG2 XDH	1.38e-03	7	243	2	C0740394
Disease	T-cell immunoglobulin and mucin domain 1 measurement	HAVCR1 CYFIP2	1.38e-03	7	243	2	EFO_0010812
Disease	hyperuricemia (implicated_via_orthology)	ABCG2 XDH	1.38e-03	7	243	2	DOID:1920 (implicated_via_orthology)
Disease	Periventricular Nodular Heterotopia	ARFGEF2 ERMARD	1.38e-03	7	243	2	C1868720
Disease	acute promyelocytic leukemia (is_implicated_in)	PML NUMA1	1.38e-03	7	243	2	DOID:0060318 (is_implicated_in)
Disease	neuroimaging measurement	VWA5B2 DCHS2 IPP BICD1 ZNF469 PKD1 ABCG2 ANGPT1 LAMC1 GALNT12 TG FADS1 EGFR VCAN NINL MACF1 PAPPA MYO16 EPHA3	1.46e-03	1069	243	19	EFO_0004346
Disease	very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio	PMPCA SYNE2 NPC1L1 SEC16B APOB CPT1A FADS1 MACF1	1.63e-03	264	243	8	EFO_0008317, EFO_0020944
Disease	cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement	HAVCR1 SYNE2 APOB CPS1 MACF1	1.65e-03	103	243	5	EFO_0008595, EFO_0020944
Disease	Miller Dieker syndrome	FANCD2 FANCB PAFAH1B1	1.72e-03	29	243	3	C0265219
Disease	urolithiasis	PDILT ABCG2 CPS1 RGS14	1.83e-03	63	243	4	MONDO_0024647
Disease	Unilateral agenesis of kidney	FREM1 GREB1L	1.83e-03	8	243	2	C0266294
Disease	Embryonal Rhabdomyosarcoma	BUB1B SETD2	1.83e-03	8	243	2	C0206656
Disease	level of Sphingomyelin (d38:1) in blood serum	GC SYNE2 NLRP1	1.90e-03	30	243	3	OBA_2045180
Disease	cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement	PMPCA SEC16B APOB CPT1A DNAH1 AZIN1 FADS1 MACF1	2.15e-03	276	243	8	EFO_0004612, EFO_0020943
Disease	intestinal cancer (implicated_via_orthology)	MRE11 EGFR FYN	2.29e-03	32	243	3	DOID:10155 (implicated_via_orthology)
Disease	Squamous cell carcinoma of lung	EGFR FYN EPHA3	2.29e-03	32	243	3	C0149782
Disease	pyoderma gangrenosum	SERPINB5 USP15	2.34e-03	9	243	2	EFO_0006835
Disease	1-ribosyl-imidazoleacetate measurement	DHTKD1 CPS1	2.34e-03	9	243	2	EFO_0800034
Disease	Disorder of fatty acid metabolism	CPT1A CPT2	2.34e-03	9	243	2	cv:C0268634
Disease	Gout	ABCG2 XDH	2.34e-03	9	243	2	C0018099
Disease	lymphocyte count	GC TRIP12 HAVCR1 ZNF469 NFATC1 UCHL5 PDILT NXF2 MRTFA DCAF12 PCDHGB7 PCDHGA9 CPS1 LMAN1L GLMN SETD2 SLC12A1 EGFR PUS10 PAPPA GSG1L MORC3 HBB	2.39e-03	1464	243	23	EFO_0004587
Disease	nephrolithiasis	PDILT ABCG2 RGS14	2.51e-03	33	243	3	EFO_0004253
Disease	phosphatidylcholine 38:5 measurement	DICER1 LRPPRC FADS1	2.51e-03	33	243	3	EFO_0010387
Disease	Chloracne	EGFR HBB HBD	2.51e-03	33	243	3	C0263454
Disease	Disease Exacerbation	ABCA13 PHB1 CLCN3 ABCF2 NBAS EGFR	2.53e-03	165	243	6	C0235874
Disease	Cardiomyopathies, Primary	MAP3K5 SGCB TLR2 MYBPC3	2.55e-03	69	243	4	C0033141
Disease	Myocardial Diseases, Secondary	MAP3K5 SGCB TLR2 MYBPC3	2.55e-03	69	243	4	C0036529
Disease	antihyperlipidemic drug use measurement	GC HAVCR1 NPC1L1 APOB FADS1	2.68e-03	115	243	5	EFO_0803367
Disease	Nephroblastoma	DDX1 NBAS	2.91e-03	10	243	2	Orphanet_654
Disease	Human papillomavirus infectious disease (is_marker_for)	EGFR TLR3	2.91e-03	10	243	2	DOID:11166 (is_marker_for)
Disease	brain ischemia (implicated_via_orthology)	LONP1 MMP13 VIP	2.97e-03	35	243	3	DOID:2316 (implicated_via_orthology)
Disease	monocyte count	GON4L GC MAP3K5 PHB1 PKD1 SEMA4A LMNTD1 MRTFA DCAF12 ANGPT1 GLMN SETD2 EGFR VCAN DUSP16 ITSN2 GSG1L MYO16 ELL TGS1 MYBPC3	3.17e-03	1320	243	21	EFO_0005091
Disease	multiple myeloma (is_marker_for)	ABCG2 PML XDH	3.22e-03	36	243	3	DOID:9538 (is_marker_for)
Disease	urate measurement	HSP90B2P GON4L DDX1 USP38 PDILT ABCG2 XDH PPM1K CPS1 CPT1A DNAH1 RGS14 SLC12A1 NISCH NINL HBB	3.23e-03	895	243	16	EFO_0004531
Disease	Liver carcinoma	PHB1 FANCD2 FASN AKR1B10 TONSL BUB1B CCNA1 PYGL ATG7 SCAP EGFR	3.41e-03	507	243	11	C2239176
Disease	3-methylglutarylcarnitine (2) measurement	CPS1 CPT2	3.54e-03	11	243	2	EFO_0800074
Disease	level of Sphingomyelin (d34:0) in blood serum	SYNE2 FADS1	3.54e-03	11	243	2	OBA_2045176
Disease	level of Sterol ester (27:1/20:5) in blood serum	CPT1A FADS1	3.54e-03	11	243	2	OBA_2045197
Disease	lignoceroylcarnitine (C24) measurement	CPT1A CPT2	3.54e-03	11	243	2	EFO_0800541
Disease	Malignant neoplasm of breast	PKDREJ PHB1 FASN SERPINB5 SYNE2 NLE1 ABCG2 MRE11 ARFGEF2 XDH CPT1A SETD2 EGFR NISCH ITSN2 MACF1 ZFYVE26 KAT6B	3.62e-03	1074	243	18	C0006142
Disease	hepatocellular carcinoma (is_marker_for)	CAB39 HAVCR1 SERPINB5 PML CPS1 EGFR PAFAH1B1 TLR3	3.65e-03	301	243	8	DOID:684 (is_marker_for)
Disease	cortical surface area measurement	TRPM6 DCHS2 ZNF354C ZNF469 USP38 PMPCA PKD1 SLC9A8 ANGPT1 LAMC1 GALNT12 CPS1 TG ARHGAP1 EGFR VCAN PAFAH1B1 MACF1 PAPPA MYO16 EPHA3	3.93e-03	1345	243	21	EFO_0010736
Disease	monounsaturated fatty acids; 16:1, 18:1 measurement	HAVCR1 APOB CPT1A FADS1	3.97e-03	78	243	4	EFO_0022187
Disease	obsolete_red blood cell distribution width	TIGD4 PPP1R3G LONP1 RAB9A PMPCA SYNE2 ALAS2 HERC1 DCAF12 MTIF3 HBD APOB CPS1 AP3B1 FREM3 FADS1 HBB HBD GPSM1 MYO16 ELL	4.00e-03	1347	243	21	EFO_0005192
Disease	pancreatitis (biomarker_via_orthology)	XDH TLR2 TLR3	4.05e-03	39	243	3	DOID:4989 (biomarker_via_orthology)
Disease	platelet component distribution width	WASF3 HAVCR1 ATP13A3 HERC1 USP15 DCAF12 ANGPT1 CPS1 LMAN1L SETD2 FADS1 EGFR MACF1 TGS1	4.18e-03	755	243	14	EFO_0007984
Disease	arachidonoylcarnitine (C20:4) measurement	CPT1A FADS1	4.22e-03	12	243	2	EFO_0800544
Disease	intracranial aneurysm (is_implicated_in)	PKD1 VCAN	4.22e-03	12	243	2	DOID:10941 (is_implicated_in)
Disease	1-myristoyl-2-arachidonoyl-GPC (14:0/20:4) measurement	GREB1L FADS1	4.22e-03	12	243	2	EFO_0800453
Disease	total blood protein measurement	IPP MAP3K5 PMPCA PKD1 DCAF12 CPS1 DNAH1 SETD2 FADS1 MACF1	4.30e-03	449	243	10	EFO_0004536
Disease	physical activity measurement	ERAP2 HERC1 PML DPY19L1 AP3B1 RGS16 LRPPRC	4.35e-03	245	243	7	EFO_0008002
Disease	lipoprotein-associated phospholipase A(2) measurement	ABCG2 APOB AP3B2	4.35e-03	40	243	3	EFO_0004746
Disease	lean body mass	KCNMA1 PML MTIF3 SEC16B CPS1 AP3B1 VCAN PAPPA MAPKBP1	4.40e-03	379	243	9	EFO_0004995
Disease	blood urea nitrogen measurement	GON4L DDX1 USP38 NFATC1 PDILT BUB1B WDR90 CPS1 RGS14 EGFR	4.50e-03	452	243	10	EFO_0004741
Disease	diabetes mellitus (is_marker_for)	GC APOB EGFR	4.67e-03	41	243	3	DOID:9351 (is_marker_for)
Disease	mean corpuscular hemoglobin concentration	IFT140 TIGD4 GON4L PHB1 LONP1 ALAS2 DCAF12 ANGPT1 WASHC2C ARFGEF2 CPS1 FADS1 EGFR MACF1 HBB FYN MYO16 ELL	4.84e-03	1105	243	18	EFO_0004528
Disease	cardiovascular disease	FREM1 PHB1 USP38 ERAP2 AKR1B10 PDILT NPC1L1 ATG7 APOB MYBPC3	4.85e-03	457	243	10	EFO_0000319
Disease	mean platelet volume	TM7SF3 NFATC1 SYNE2 ATP13A3 MRTFA PCDHGB7 PCDHGA9 MAN1C1 NUMA1 CPS1 AZIN1 SETD2 FADS1 PAFAH1B1 TGS1 MYBPC3 NIN	4.90e-03	1020	243	17	EFO_0004584
Disease	Connective Tissue Diseases	ZNF469 PKD1	4.96e-03	13	243	2	C0009782
Disease	level of Phosphatidylcholine (16:1_18:1) in blood serum	GREB1L FADS1	4.96e-03	13	243	2	OBA_2045082
Disease	triglycerides in large LDL measurement	HAVCR1 SYNE2 APOB	5.34e-03	43	243	3	EFO_0022319
Disease	serum metabolite measurement	IPP GC NFATC1 ERAP2 SYNE2 TRPM8 ABCG2 MROH9 ANGPT1 APOB PPM1K CPS1 CPT1A CPT2 LRPPRC FADS1	5.41e-03	945	243	16	EFO_0005653
Disease	C-reactive protein measurement	DCHS2 TRIP12 ZNF469 PKD1 KCNN3 ABCG2 ARL14EP SEC16B APOB ATP9A CYFIP2 GLMN FADS1 GTF3C2 SPHKAP MACF1 SERPINA10 EPHA3 MYBPC3	5.45e-03	1206	243	19	EFO_0004458
Disease	free cholesterol:total lipids ratio, intermediate density lipoprotein measurement	PMPCA APOB CPT1A FADS1	5.62e-03	86	243	4	EFO_0008595, EFO_0020945

Protein segments in the cluster

Peptide	Gene	Start	Entry
EDGNHTSLELGKSLF	ZNF354C	156	Q86Y25
GVFDTTFQSHLNKAL	BUB1B	1021	O60566
FSELFHLLSSGNCKT	BHLHB9	446	Q6PI77
FIHLVGDALKAFQSS	ADGRB2	701	O60241
LISGTKAIFKFDSNH	ERBIN	936	Q96RT1
LSLTFHGQELLSDTK	ABCF2	91	Q9UG63
FHVKLTDSALRAFES	ELL	26	P55199
GHFLDFLTESQVLDS	CCDC116	71	Q8IYX3
DLSKQLGFFSFPITH	CCDC116	456	Q8IYX3
LEQLKEAFGQSFSIH	BICD1	66	Q96G01
LFSTDKSHSDIGFQL	CSMD2	841	Q7Z408
EKSHFFLATALVTES	VCAN	2201	P13611
GTLFLGHFLKNESSE	ADGRG4	156	Q8IZF6
EGHFATITLTFIDKN	AHSA1	281	O95433
EHTLTGKNAFFVGDL	AZIN1	31	O14977
ELDHSKPLLSFSFGQ	ALKBH1	236	Q13686
NGKSFSVILEHFQDL	ATP13A3	831	Q9H7F0
KSSFITALAGELEHS	BCS1L	236	Q9Y276
HVIDLDDATFLSAKF	ARL14EP	91	Q8N8R7
FHSSNVIDGLKLNAF	GSG1L	161	Q6UXU4
NDLKAFTEGAVLSFH	ABCG2	26	Q9UNQ0
LFKLLDCLQESHSFS	ARFGEF2	1611	Q9Y6D5
LVGENLINFHISSKF	CPT1A	726	P50416
LKSQFGFDDLHTEQI	ABCA13	276	Q86UQ4
ALGVSNFSHFQIEKL	AKR1B10	156	O60218
ASDAFATFKDLLTRH	CAB39	181	Q9Y376
SSLILHGADFSTKDA	ANGPT1	416	Q15389
TLDFNDTFLSIEHLK	AQR	711	O60306
DTFLSIEHLKASFPG	AQR	716	O60306
LGSIENSFQKFHAFL	CEP78	521	Q5JTW2
AKLTHLFDNDGTVVF	ANO9	256	A1A5B4
QISVSLTEHFLKFAS	C3orf70	96	A6NLC5
LESQEFDHFLATKFS	DHTKD1	171	Q96HY7
DKTLNHLISGFENFE	DICER1	1656	Q9UPY3
SFEDRVHFSGKLLLQ	DNAI3	361	Q8IWG1
FKDRDHFQLGTLSHT	AP3B1	611	O00203
VLESSFKDRDHFQLG	AP3B2	611	Q13367
FNLIIAKDGSTAVHF	CPT2	356	P23786
DDVSLTHLTFGKEFT	PHB1	166	P35232
LFSDQLLAVLVKSHF	RBM43	26	Q6ZSC3
HFGDKIFSSVNAILD	RBM43	101	Q6ZSC3
TLAFLEIDKAFSSHA	PPM1K	161	Q8N3J5
HLSLEEFSSGLKNIF	RAB44	96	Q7Z6P3
KFDTQLFHTIGVEFL	RAB9A	31	P51151
KFDSQAFHTIGVEFL	RAB9B	31	Q9NP90
IETTLAKIFGLFHDQ	GUCY2C	741	P25092
SNKELHGFLFNDFLL	ITSN2	1446	Q9NZM3
FLEVHSGEEFLALTK	IPP	166	Q9Y573
DSVQDISFDHSGKLL	PAFAH1B1	151	P43034
EKLHFSVDAQSGDLL	PCDHGB7	71	Q9Y5F8
TNSQLKALFDGLSHI	KAT6B	536	Q8WYB5
HGLDLETSNKDFTSI	KCNG3	346	Q8TAE7
NSTTHSFLFGALAEL	MORC1	21	Q86VD1
FSFSLEESLKRAHVS	PAXIP1	956	Q6ZW49
HFTAEGEVTFKSILF	HSP90B2P	31	Q58FF3
QFLSKDADGDTFLHI	NFKBIZ	436	Q9BYH8
ITLESVSNFLKDFLH	KCNMA1	416	Q12791
HLKIQEGTLGFFIAS	KCNMA1	651	Q12791
ILAFEGHLAAASTKQ	INTS1	806	Q8N201
LEAFGHAKTTLNDLS	MYO16	536	Q9Y6X6
LLGNFTEATTFHKER	GPSM1	221	Q86YR5
ILAVHSDFFQKLFLS	IBTK	581	Q9P2D0
LHSVSSKSFRDFLLE	IBTK	1196	Q9P2D0
LEAKSIHLSINFFSL	MMRN1	906	Q13201
GTLADDHDVLSFLTF	LMAN1L	236	Q9HAT1
FESDFDLTKSLGVHT	HERC1	1576	Q15751
SLTGQSLFDFLHPKD	ARNTL2	221	Q8WYA1
LGFASEQHLTQFAEK	HOMER3	91	Q9NSC5
AALEKEAQTSFLHLG	DDX1	716	Q92499
LSFLIHAKAFSTAED	MTIF3	46	Q9H2K0
IGSLESKLEHLTASF	KCNN3	656	Q9UGI6
ESKASLAAILEHSLF	MORC3	161	Q14149
VHFEDTGKTLLFSGN	MMP13	386	P45452
EFSLTADSRKSHLIF	PCDHGA9	756	Q9Y5G4
DLSFNVLTDAGAKHL	NLRP1	871	Q9C000
FDLDSSLLHLKSFSS	FAM214A	831	Q32MH5
KEVFAFFSHQLLDSL	DNAH8	836	Q96JB1
LENTTTGEFIHEKFS	FREM1	1681	Q5H8C1
EHAQGTLRSAKLFFD	GCGR	371	P47871
LSGHNFLQDSKVIFV	NFATC1	616	O95644
DDAHIGNLLTSKFFS	DPY19L1	366	Q2PZI1
AIALKEGFHFEETLT	PGM2	386	Q96G03
VGIFLLHAFKDVSFS	NIPA2	291	Q8N8Q9
VLNKESHSPFGLDSF	KDM3B	1246	Q7LBC6
SHEEKLSGFIASELA	MACF1	611	O94854
LTKTNIDEHFFGVAL	LCA5L	6	O95447
AFAETHIKGFTLNDA	LRPPRC	1091	P42704
FLSLFGDSKKLTAHS	LMNTD1	106	Q8N9Z9
ELSKLGLLDNHSSEF	LONP1	441	P36776
SFLDVIALKHGFDTL	MOCOS	321	Q96EN8
SLAADFSITQFKHLG	ATP9A	811	O75110
LHASSGFTEEFETLK	PTPRZ1	1711	P23471
DFTLTGLFAESKHAA	OR2T34	16	Q8NGX1
DFTLTGLFAESKHAA	OR2T3	16	Q8NH03
KLDGSTHLNIFFAKS	PAPPA	506	Q13219
THLNIFFAKSSEEEL	PAPPA	511	Q13219
KQSFFFTHLLNISEA	CYFIP2	621	Q96F07
AASILIFTLEFHAEK	MROH9	276	Q5TGP6
KTFFILHDINSDGVL	NUCB1	246	Q02818
GSDADLVVFHNSLKS	OAS2	406	P29728
FLASHFKTTSLGDDL	GREB1L	606	Q9C091
SFHLTEEDSKLLVFF	NBAS	2116	A2RRP1
CSDFQFKLHELTSLL	POF1B	496	Q8WVV4
LHQKDSALLFSSCFV	ALAS2	246	P22557
LLHESLFGSVADDQK	RBBP7	236	Q16576
QLKFISGHTSELGDF	MOGS	226	Q13724
GLFDDSLTHLFLFSL	OR2AE1	16	Q8NHA4
HFEIDSSTGDLFLSK	DCHS2	1451	Q6V1P9
STGFFTIKEENSHLK	FANCB	61	Q8NB91
SDKLSFSTHTLLGQF	NPC1L1	326	Q9UHC9
LISDHLLAVFKAESF	PUS10	321	Q3MIT2
HFKALFVSFLEESIS	DNAH1	2036	Q9P2D7
NKLTQLGTFEDHFLS	EGFR	36	P00533
STKNHLQLEGLFFTN	APOB	3566	P04114
LFFTNGEHTSKATLE	APOB	3576	P04114
LHNEGFKLFATEATS	CPS1	1381	P31327
LNGVFIHDQKLFTDF	CCPG1	686	Q9ULG6
VDELISSAIFHFKAA	IFIT5	316	Q13325
AKVFNSSHSFLEDLT	ATG7	666	O95352
KTALHSGEDFQTLLF	C1QTNF6	151	Q9BXI9
FTEDFFNLTLKELHL	B3GNT4	186	Q9C0J1
FLTSFSGKLREHELN	CPLANE1	1576	Q9H799
EREFHLGTLNKVFAS	DCAF12	81	Q5T6F0
ALELDGQSVKAHFFL	STUB1	86	Q9UNE7
LSFHKGEKFQILNSS	FYN	101	P06241
LEKSFNSVHLLAGGF	DUSP16	111	Q9BY84
TGTLKSDLHFLLDFN	CCNA1	166	P78396
VKSLAVGENDFHFAL	COL6A3	66	P12111
IKFLQEHGSDSFLAE	FKBP3	26	Q00688
GDSAQFTKALAIILH	FEM1A	486	Q9BSK4
LKELGTFAQSSIALH	GON4L	726	Q3T8J9
FILQEDGSLFHEQSK	GALNT12	531	Q8IXK2
VSTLKDLFGLASNEH	APPL2	126	Q8NEU8
SLDSFLRKHDAQFTV	EPHA3	706	P29320
TFLSAELALLQKSFH	BPIFB6	261	Q8NFQ5
SAFADIIHSLKESGQ	FADS1	421	O60427
KLGSFEGLVNLTFIH	LUM	151	P51884
ENLGNLIHETESFFK	IFFO2	411	Q5TF58
SSILAEFGSLHLEFL	MAN1C1	321	Q9NR34
EQFLKQHFETLASGA	MAPKBP1	1066	O60336
LHFLDKAGSVSLDSV	FMNL1	901	O95466
LFFESLEAQGSHLDI	ERAP2	916	Q6P179
SSINLTLHLGKAFDI	LAMC1	131	P11047
EAVHSHFLSLTKGQF	ERMARD	76	Q5T6L9
LAHLDNLKGTFSQLS	HBD	76	P02042
LAHLDNLKGTFATLS	HBB	76	P68871
KSVDDVLSHFAQRLF	DNAAF5	241	Q86Y56
HKTAFVEHLNGSFLF	DRC3	236	Q9H069
KLLTSGGLNEDFSFH	EIF2B2	111	P49770
LKNVTFHGVLLDAFF	FASN	1786	P49327
EILKGHTQDTNTFFL	FLAD1	121	Q8NFF5
DTHSSIFDAKAGIAL	GAPDHS	361	O14556
HITVFGLSNKFDTEF	CHIC1	96	Q5VXU3
NGSLDFFSLETHTAL	SCAP	1026	Q12770
VGTDLAHFKSFDLSR	IFT140	536	Q96RY7
AGHFSKALELAFATQ	IFT140	1091	Q96RY7
FLEQAFDKLSESGFH	KCTD12	276	Q96CX2
ASFKILSLEETESHG	KCTD3	466	Q9Y597
IAGENTIFFHISSKF	CPT1B	726	Q92523
EEKTSLLLHNSHAFF	FANCD2	911	Q9BXW9
VTKFSSVFLGLEHLQ	PRAMEF13	256	Q5VWM6
LDSSFLTFSGLHAEQ	PKD1	3376	P98161
FSHLADLQGLLFSVF	OR10C1	16	Q96KK4
GDLSFKLREFASHLQ	NUMA1	321	Q14980
GAFLTKNHAIFSEDL	MTERF3	206	Q96E29
NFTGSETLKHLVLQF	NXF2	381	Q9GZY0
LEDFHFAQKTTLTSI	MROH2A	841	A6NES4
TLETLHFGKLDFGET	MAP3K5	126	Q99683
TLKGFSDFLESHIKT	PDILT	481	Q8N807
VGFQKQHDAFSLILS	FREM3	1026	P0C091
KVLHSALFTFDLIES	GLMN	556	Q92990
AFFVHDAEIVSSLGK	NLE1	61	Q9NVX2
SGIAHFLEKLAFSST	PMPCA	106	Q10713
HFNVLFDGLSKLAAD	VAC14	131	Q08AM6
FLSKSSLLEEAEGHS	SPHKAP	1446	Q2M3C7
AFSTLIDKGTHVAFL	TBC1D31	446	Q96DN5
NLLDAFSIKLSETHG	SYNE2	1401	Q8WXH0
LEENTTLLGFQDKHF	NIN	1431	Q8N4C6
SISLHSFSLADFDRK	PKDREJ	1946	Q9NTG1
KAVSLEVGLQHFLSF	PML	651	P29590
SQSLTVIHDFLFSLK	FAF2	381	Q96CS3
LFLEHSLLTANTTKG	HAVCR1	281	Q96D42
INTFTKFLLDHQGEL	ARHGAP1	416	Q07960
FHQKGLQDFDTLLLS	SEMA4A	56	Q9H3S1
SFNDTFVHVTDLSGK	RPS14	36	P62263
LGLSIFSFPHKFEIS	SLC9A8	366	Q9Y2E8
ALLDITHAFTKNSGL	SLC12A1	696	Q13621
LLSSAVDHGSDEVKF	CCT2	141	P78371
LGLKHIFSEDTSDFS	SERPINB5	291	P36952
DTLGLSLASVKHFSE	PPP1R3G	136	B7ZBB8
GSLHIIDDFESKFTF	WIPF3	411	A6NGB9
DGEVKSSIFFLTIHD	SLC26A3	701	P40879
GLTSEILNSFEHEFL	POLA2	56	Q14181
ILNSFEHEFLSKRLS	POLA2	61	Q14181
EFHESGLLRFKQVSD	SGCB	101	Q16585
NTFKILVATDIHLGF	MRE11	11	P49959
GKVSLEEFQLGLFSH	NINL	251	Q9Y2I6
FEKGSVLFNIGALHT	RHPN1	211	Q8TCX5
SLFSTDFLDGHDLQL	MRTFA	911	Q969V6
KASFNLEDGHASSLE	STRA8	111	Q7Z7C7
AFDDTFFNLTLKEIH	B3GNT9	196	Q6UX72
ADFLLKSSFSSFLEH	ANKUB1	471	A6NFN9
GSFHKSLDQIFETLE	CDCA4	156	Q9BXL8
FLDAKEEFTHTTLAA	CLCN3	641	P51790
DLKIGFFSTDHATQT	C10orf67	76	Q8IYJ2
NECGTFFSEKLVLHL	ZNF37A	246	P17032
SFDFLKDITTLLHSL	TRIM69	266	Q86WT6
HLGETLSEFKEFSQS	UCHL5	106	Q9Y5K5
TSHLNDTFRFDSEKL	PDCD11	956	Q14690
EQRFFLGHTDKVSAL	WDR90	401	Q96KV7
DKTFAFCTNLTELHL	TLR3	116	O15455
FGSLAFALSQLGDHK	TTC24	316	A2A3L6
FIKDSLLSLDSQVGH	TRPM6	1196	Q9BX84
LHSEITSLFKDVFGT	MUC13	241	Q9H3R2
KSDFFELLSNHHLDS	TCERG1	796	O14776
FSFAHQTISALIKAE	VPS35	561	Q96QK1
LGSAFQDAEHLKTLS	TONSL	1181	Q96HA7
LSSLSKHAEDIFGEL	WASF3	41	Q9UPY6
FDLSIFKSLHQVEIS	NISCH	211	Q9Y2I1
DTEKLVAFLFGITSH	GPLD1	111	P80108
KEFTFSLLDAVDTLH	TIGD4	346	Q8IY51
EFSHLGKEDFTSLSL	GC	31	P02774
EFHSILSFGVESSIK	UBR1	1271	Q8IWV7
DSIIVDIFHGLFKST	USP15	431	Q9Y4E8
FAVFEGLHLSTSEKI	SLC35C2	216	Q9NQQ7
GLHLSTSEKIFRFQD	SLC35C2	221	Q9NQQ7
EGLLSSGKHFFVELS	SEZ6	496	Q53EL9
STGVFQDEELLFSHK	WASHC2C	836	Q9Y4E1
GDLTHFNQKLEGFTL	XDH	951	P47989
GFKIVSKDLTNSHFF	RRP8	411	O43159
DLGFLAFVSSKSESH	RGS14	271	O43566
FDLLLSSKNGVAAFH	RGS16	66	O15492
FEHQLIKLSDVFGSV	GTF3C4	461	Q9UKN8
FLSHFGFLSLEALKE	RALGAPB	1111	Q86X10
FESFFNKTFVLGLLH	USP38	76	Q8NB14
VLKNGSLTNHFSFEK	GART	791	P22102
DLSSEFILASKGLTH	SLF1	971	Q9BQI6
GSHFSDQSDKFLLSL	SETD2	1346	Q9BYW2
LLGSSHSQEFLKFAT	SEC16B	586	Q96JE7
LELGLTQGSFAFIHK	SERPINA10	156	Q9UK55
LSHAKTFLLAGDAQA	ZNF469	791	Q96JG9
LFLLDSSSVAHKDAI	VWA5B2	356	Q8N398
STGVFQDEELLFSHK	WASHC2A	836	Q641Q2
SFHNVAEATFTLKLI	ZGRF1	1931	Q86YA3
LLFQDTDLGSFHDLL	GTF3C2	796	Q8WUA4
LQFGRITAHKDFEVS	TGS1	101	Q96RS0
KFLTHDVLTELFSNH	TRPM8	486	Q7Z2W7
HDSRAVKFLFEILSS	TRIP12	1891	Q14669
SGKFSSLLQALEIQH	TRIM65	181	Q6PJ69
ESLTKENIFSETAFH	TNNI3K	296	Q59H18
LSQLTKLHSFLGDDV	PYGL	516	P06737
ITTFSKEQLDSFHTL	TLR2	511	O60603
DLIQSGSFQLHLDSK	TG	1401	P01266
GSFQLHLDSKTFPAE	TG	1406	P01266
LFELLFADHVSSSLK	VIRMA	486	Q69YN4
KAFAFVSEAHVLSSL	ZP2	596	Q05996
LDLKHFTSGISGFLA	ZFYVE26	666	Q68DK2
HADGVFTSDFSKLLG	VIP	81	P01282
LQEFEEKSGRTFLHT	SSU72	176	Q9NP77
TSILQALLKAFSFHD	VWA3A	1036	A6NCI4
TFFTPLGNLKIFHDD	TM7SF3	391	Q9NS93
AFTSTLEKVGDHQFL	KIAA2013	231	Q8IYS2
SHEDTGILDFSSLLK	MYBPC3	286	Q14896